CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: quercetin O-glycoside
Accession: CHEBI:76424
browse the term
Definition: Any glycosyloxyflavone that is an O-glycosylated derivative of quercetin.
Synonyms: related_synonym: quercetin O-glycosides
G
Acadm
acyl-CoA dehydrogenase medium chain
multiple interactions
EXP
quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA]
CTD
PMID:26190035
NCBI chr 2:260,124,418...260,148,589
Ensembl chr 2:260,124,418...260,148,589
G
Adrb2
adrenoceptor beta 2
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine binds to ADRB2 protein]
CTD
PMID:24929186
NCBI chr18:57,513,792...57,515,834
Ensembl chr18:57,513,793...57,515,834
G
Agt
angiotensinogen
multiple interactions
ISO
quercetin 3-O-glucuronide analog inhibits the reaction [AGT protein results in increased phosphorylation of JUN protein]
CTD
PMID:12054679
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
G
Alox5
arachidonate 5-lipoxygenase
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [ALOX5 protein results in increased chemical synthesis of Leukotriene B4]
CTD
PMID:18096136
NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303
G
App
amyloid beta precursor protein
multiple interactions decreases expression
ISO
quercetin 3-O-glucuronide inhibits the reaction [APP protein binds to APP protein modified form] quercetin 3-O-glucuronide results in decreased expression of APP protein
CTD
PMID:23097297
NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
G
Cat
catalase
multiple interactions
EXP
[quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of CAT mRNA; [quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of CAT protein
CTD
PMID:25716194
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
G
Cav1
caveolin 1
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA]
CTD
PMID:27257344
NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
G
Cd36
CD36 molecule
decreases expression
ISO
quercetin 3-O-glucuronide results in decreased expression of CD36 mRNA
CTD
PMID:18199750
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
G
Cpt1a
carnitine palmitoyltransferase 1A
multiple interactions
EXP
quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of CPT1A mRNA]
CTD
PMID:26190035
NCBI chr 1:218,568,157...218,629,679
Ensembl chr 1:218,569,510...218,629,678
G
Fas
Fas cell surface death receptor
multiple interactions
EXP
quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FAS mRNA]; quercetin 3-O-glucuronide inhibits the reaction [Dietary Fats results in increased expression of FAS mRNA]
CTD
PMID:26190035
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions
EXP
[quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of GCLC mRNA; [quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of GCLC protein
CTD
PMID:25716194
NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
G
Hmox1
heme oxygenase 1
multiple interactions
ISO EXP
quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased expression of HMOX1 mRNA] [quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of HMOX1 mRNA; [quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of HMOX1 protein
CTD
PMID:24929186 PMID:25716194
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [Lysophosphatidylcholines results in increased expression of ICAM1 mRNA]
CTD
PMID:27257344
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [Palmitates results in increased phosphorylation of IKBKB protein]
CTD
PMID:23504962
NCBI chr16:74,177,233...74,230,809
Ensembl chr16:74,177,215...74,230,815
G
Il1b
interleukin 1 beta
multiple interactions
EXP
quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]
CTD
PMID:26190035
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il6
interleukin 6
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [Palmitates results in increased secretion of IL6 protein]
CTD
PMID:23504962
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Ins2
insulin 2
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased chemical synthesis of Nitric Oxide]]; quercetin 3-O-glucuronide inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]]; quercetin 3-O-glucuronide inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]]
CTD
PMID:23504962
NCBI chr 1:215,856,967...215,858,034
Ensembl chr 1:215,856,971...215,858,034
G
Irs1
insulin receptor substrate 1
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]]; quercetin 3-O-glucuronide inhibits the reaction [Palmitates results in increased phosphorylation of IRS1 protein]
CTD
PMID:23504962
NCBI chr 9:88,033,668...88,086,488
Ensembl chr 9:88,033,668...88,086,488
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
quercetin 3-O-glucuronide analog inhibits the reaction [AGT protein results in increased phosphorylation of JUN protein]
CTD
PMID:12054679
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased expression of MMP2 mRNA]
CTD
PMID:24929186
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased activity of MMP9 protein]; quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]
CTD
PMID:24929186
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
Msr1
macrophage scavenger receptor 1
decreases expression
ISO
quercetin 3-O-glucuronide results in decreased expression of MSR1 mRNA
CTD
PMID:18199750
NCBI chr16:56,817,714...56,900,025
Ensembl chr16:56,813,791...56,900,052
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein]
CTD
PMID:27257013
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
G
Nos3
nitric oxide synthase 3
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]]
CTD
PMID:23504962
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
EXP
quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA protein]; quercetin 3-O-glucuronide inhibits the reaction [Dietary Fats results in decreased expression of PPARA protein]
CTD
PMID:26190035
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression
ISO
quercetin 3-O-glucuronide results in increased expression of PPARG mRNA
CTD
PMID:25765892
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of PTGS2 protein]
CTD
PMID:27257013
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [Palmitates results in increased phosphorylation of RELA protein]
CTD
PMID:23504962
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
G
Slc22a8
solute carrier family 22 member 8
multiple interactions increases uptake
ISO
quercetin 3-O-glucuronide analog inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein]; quercetin 3-O-glucuronide inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein] SLC22A8 protein results in increased uptake of quercetin 3-O-glucuronide analog
CTD
PMID:21244849
NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
EXP
quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of SREBF1 mRNA]; quercetin 3-O-glucuronide inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA]
CTD
PMID:26190035
NCBI chr10:46,570,996...46,593,021
Ensembl chr10:46,570,996...46,593,009
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
quercetin 3-O-glucuronide inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with TNF protein] results in increased expression of VCAM1 protein]; quercetin 3-O-glucuronide inhibits the reaction [Palmitates results in increased secretion of TNF protein] quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]
CTD
PMID:17880982 PMID:23504962 PMID:26190035
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tnfsf11
TNF superfamily member 11
decreases activity
ISO
quercetin 3-O-glucuronide results in decreased activity of TNFSF11 protein
CTD
PMID:19495926
NCBI chr15:60,482,527...60,512,704
Ensembl chr15:60,482,527...60,512,704
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
ISO
quercetin 3-O-glucuronide inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with TNF protein] results in increased expression of VCAM1 protein]
CTD
PMID:17880982
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
G
Ache
acetylcholinesterase
increases expression multiple interactions
EXP
hyperoside results in increased expression of ACHE mRNA hyperoside results in increased expression of and results in increased activity of ACHE protein
CTD
PMID:27019979
NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO EXP
hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of BAX protein] hyperoside inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein]
CTD
PMID:18552516 PMID:31326407
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP
hyperoside inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]
CTD
PMID:31326407
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions
ISO
[Quercetin co-treated with hyperoside] results in decreased expression of BIRC5 mRNA; [Quercetin co-treated with hyperoside] results in decreased expression of BIRC5 protein
CTD
PMID:24173369
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
G
Casp3
caspase 3
multiple interactions
ISO
[Quercetin co-treated with hyperoside] results in increased cleavage of CASP3 protein
CTD
PMID:24173369 PMID:25354548
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Cat
catalase
multiple interactions
EXP
cyclopamine inhibits the reaction [hyperoside inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein]]; hyperoside inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein]
CTD
PMID:31326407
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
G
Cycs
cytochrome c, somatic
multiple interactions
ISO
hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of CYCS protein]
CTD
PMID:18552516
NCBI chr 4:80,331,226...80,333,326
Ensembl chr 4:80,331,227...80,333,326
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity multiple interactions
ISO
hyperoside results in decreased activity of CYP2E1 protein hyperoside inhibits the reaction [Acetaminophen results in decreased activity of CYP2E1 protein]
CTD
PMID:26772156
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
G
Esr1
estrogen receptor 1
multiple interactions
ISO
hyperoside inhibits the reaction [Estradiol results in increased activity of ESR1 protein]
CTD
PMID:22613215
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
G
Gli1
GLI family zinc finger 1
multiple interactions increases expression
EXP
hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of GLI1 mRNA]; hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of GLI1 protein] hyperoside results in increased expression of GLI1 mRNA; hyperoside results in increased expression of GLI1 protein
CTD
PMID:31326407
NCBI chr 7:70,620,794...70,633,171
Ensembl chr 7:70,620,766...70,630,338
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
ISO
hyperoside inhibits the reaction [Acetaminophen results in increased activity of GPT protein]
CTD
PMID:26772156
NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]
CTD
PMID:30125551
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:30125551
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mir21
microRNA 21
multiple interactions
ISO
[Quercetin co-treated with hyperoside] results in decreased expression of MIR21 mRNA; MIR21 mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 mRNA]; MIR21 mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 protein]; MIR21 mRNA results in decreased susceptibility to [Quercetin co-treated with hyperoside]
CTD
PMID:25354548
NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
G
Mir27a
microRNA 27a
multiple interactions
ISO
[Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in decreased expression of ZBTB10 mRNA]; [Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in increased expression of SP1 mRNA]; [Quercetin co-treated with hyperoside] results in decreased expression of MIR27A mRNA; MIR27A mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of ZBTB10 mRNA]
CTD
PMID:24173369
NCBI chr19:25,318,736...25,318,822
Ensembl chr19:25,318,736...25,318,822
G
Nfe2l2
nuclear factor, erythroid 2-like 2
affects localization
ISO
hyperoside affects the localization of NFE2L2 protein
CTD
PMID:26772156
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
CTD
PMID:30125551
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
Hyperoside increases expression of Nqo1 protein in liver
RGD
PMID:31399183
RGD:25823190
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
[Quercetin co-treated with hyperoside] results in increased cleavage of PARP1 protein
CTD
PMID:24173369 PMID:25354548
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
G
Pdcd4
programmed cell death 4
multiple interactions
ISO
[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 mRNA; [Quercetin co-treated with hyperoside] results in increased expression of PDCD4 protein; MIR21 mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 mRNA]; MIR21 mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 protein]
CTD
PMID:25354548
NCBI chr 1:274,616,625...274,648,204
Ensembl chr 1:274,625,224...274,648,204
G
Prima1
proline rich membrane anchor 1
increases expression
EXP
hyperoside results in increased expression of PRIMA1 mRNA
CTD
PMID:27019979
NCBI chr 6:127,075,954...127,127,985
Ensembl chr 6:127,075,954...127,127,413
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]
CTD
PMID:30125551
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
G
Shh
sonic hedgehog signaling molecule
increases expression multiple interactions
EXP
hyperoside results in increased expression of SHH mRNA; hyperoside results in increased expression of SHH protein hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SHH mRNA]; hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SHH protein]
CTD
PMID:31326407
NCBI chr 4:718,538...727,691
Ensembl chr 4:718,538...727,691
G
Sirt1
sirtuin 1
multiple interactions
ISO
hyperoside inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SIRT1 protein]
CTD
PMID:18552516
NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199
G
Smo
smoothened, frizzled class receptor
increases expression multiple interactions
EXP
hyperoside results in increased expression of SMO mRNA; hyperoside results in increased expression of SMO protein hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO mRNA]; hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO protein]
CTD
PMID:31326407
NCBI chr 4:57,019,941...57,041,779
Ensembl chr 4:57,019,941...57,042,770
G
Sp1
Sp1 transcription factor
multiple interactions
ISO
[Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in increased expression of SP1 mRNA]; [Quercetin co-treated with hyperoside] results in decreased expression of SP1 mRNA; [Quercetin co-treated with hyperoside] results in decreased expression of SP1 protein
CTD
PMID:24173369
NCBI chr 7:144,014,173...144,044,635
Ensembl chr 7:144,014,173...144,044,629
G
Sp3
Sp3 transcription factor
multiple interactions
ISO
[Quercetin co-treated with hyperoside] results in decreased expression of SP3 mRNA; [Quercetin co-treated with hyperoside] results in decreased expression of SP3 protein
CTD
PMID:24173369
NCBI chr 3:59,644,579...59,689,011
Ensembl chr 3:59,646,015...59,688,692
G
Sp4
Sp4 transcription factor
multiple interactions
ISO
[Quercetin co-treated with hyperoside] results in decreased expression of SP4 mRNA; [Quercetin co-treated with hyperoside] results in decreased expression of SP4 protein
CTD
PMID:24173369
NCBI chr 6:146,135,877...146,201,344
Ensembl chr 6:146,135,877...146,195,819
G
Sult2a1
sulfotransferase family 2A member 1
multiple interactions increases expression
ISO
hyperoside inhibits the reaction [Acetaminophen results in decreased expression of SULT2A1 mRNA] hyperoside results in increased expression of SULT2A1 mRNA
CTD
PMID:26772156
NCBI chr 1:76,558,721...76,614,315
Ensembl chr 1:76,252,329...76,780,230
G
Tnf
tumor necrosis factor
multiple interactions
ISO
hyperoside inhibits the reaction [TNF protein results in increased expression of TNFRSF1A protein]; hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]
CTD
PMID:30125551
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tnfrsf1a
TNF receptor superfamily member 1A
multiple interactions
ISO
hyperoside inhibits the reaction [TNF protein results in increased expression of TNFRSF1A protein]
CTD
PMID:30125551
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
multiple interactions increases expression
ISO
hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT1A1 mRNA] hyperoside results in increased expression of UGT1A1 mRNA
CTD
PMID:26772156
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
multiple interactions
ISO
hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT1A6 mRNA]
CTD
PMID:26772156
NCBI chr 9:95,241,609...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Ugt2b17
UDP glucuronosyltransferase family 2 member B17
multiple interactions increases expression
ISO
hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA] hyperoside results in increased expression of UGT2B1 mRNA
CTD
PMID:26772156
NCBI chr14:22,724,399...22,736,148
Ensembl chr14:22,724,070...22,825,444
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
ISO
hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]
CTD
PMID:30125551
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
G
Zbtb10
zinc finger and BTB domain containing 10
multiple interactions
ISO
[Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in decreased expression of ZBTB10 mRNA]; [Quercetin co-treated with hyperoside] results in increased expression of ZBTB10 mRNA; MIR27A mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of ZBTB10 mRNA]
CTD
PMID:24173369
NCBI chr 2:94,692,939...94,730,976
Ensembl chr 2:94,692,939...94,730,978
G
Acat2
acetyl-CoA acetyltransferase 2
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of ACAT2 mRNA
CTD
PMID:18032389
NCBI chr 1:47,972,399...47,992,654
Ensembl chr 1:47,972,399...47,992,653
G
Akr7a3
aldo-keto reductase family 7 member A3
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of AKR7A3 mRNA
CTD
PMID:20033131
NCBI chr 5:157,801,120...157,813,756
Ensembl chr 5:157,801,163...157,813,756
G
Apoa1
apolipoprotein A1
increases secretion
ISO
isoquercitrin results in increased secretion of APOA1 protein
CTD
PMID:24963805
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
G
Atf6
activating transcription factor 6
increases expression
EXP
isoquercitrin results in increased expression of ATF6 mRNA
CTD
PMID:30365939
NCBI chr13:89,053,457...89,242,531
Ensembl chr13:89,055,983...89,242,443
G
Atxn2
ataxin 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of ATXN2 mRNA]
CTD
PMID:25129099
NCBI chr12:40,264,601...40,335,637
Ensembl chr12:40,266,662...40,332,612
G
Atxn3
ataxin 3
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of ATXN3 mRNA]
CTD
PMID:25129099
NCBI chr 6:125,817,420...125,853,461
Ensembl chr 6:125,819,640...125,853,461
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
isoquercitrin results in decreased expression of BCL2 mRNA
CTD
PMID:30597948
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Casp3
caspase 3
affects expression
ISO
isoquercitrin affects the expression of CASP3 mRNA
CTD
PMID:30597948
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Casp8
caspase 8
decreases expression
ISO
isoquercitrin results in decreased expression of CASP8 mRNA
CTD
PMID:30597948
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
G
Cat
catalase
multiple interactions
EXP
[Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid co-treated with isoquercitrin analog] results in increased expression of CAT mRNA; isoquercitrin inhibits the reaction [Streptozocin results in decreased activity of CAT protein]
CTD
PMID:30298849 PMID:30817903
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA]
CTD
PMID:21295105
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
EXP
isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein]
CTD
PMID:14654164
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA]
CTD
PMID:21295105
NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
G
Ctnnb1
catenin beta 1
affects expression
ISO
isoquercitrin affects the expression of CTNNB1 mRNA
CTD
PMID:30597948
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CXCL2 protein]
CTD
PMID:14654164
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions decreases activity
EXP ISO
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A1 mRNA isoquercitrin results in decreased activity of CYP1A1 protein
CTD
PMID:16271822 PMID:20033131
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA
CTD
PMID:20033131
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
isoquercitrin results in decreased activity of CYP1B1 protein
CTD
PMID:16271822
NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of CYP2B2 mRNA]
CTD
PMID:20033131
NCBI chr 1:83,103,925...83,119,578
Ensembl chr 1:83,103,925...83,119,193
G
Cyp51
cytochrome P450, family 51
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of CYP51A1 mRNA
CTD
PMID:18032389
NCBI chr 4:27,175,564...27,194,018
Ensembl chr 4:27,175,243...27,194,018
G
Dhcr7
7-dehydrocholesterol reductase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of DHCR7 mRNA
CTD
PMID:18032389
NCBI chr 1:217,018,916...217,034,890
Ensembl chr 1:217,018,916...217,034,904
G
Egf
epidermal growth factor
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein]
CTD
PMID:26109002
NCBI chr 2:68,820,616...68,895,537
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]
CTD
PMID:26109002
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
G
Egln1
egl-9 family hypoxia-inducible factor 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of EGLN1 mRNA]
CTD
PMID:25129099
NCBI chr19:57,660,194...57,701,158
Ensembl chr19:57,662,278...57,699,113
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of FDFT1 mRNA
CTD
PMID:18032389
NCBI chr15:46,339,248...46,367,302
Ensembl chr15:46,339,249...46,367,302
G
Fdps
farnesyl diphosphate synthase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of FDPS mRNA
CTD
PMID:18032389
NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
[isoquercitrin analog co-treated with Propylthiouracil] results in decreased expression of FOS mRNA
CTD
PMID:31068541
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Gpx2
glutathione peroxidase 2
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GPX2 mRNA
CTD
PMID:20033131
NCBI chr 6:99,839,960...99,843,245
Ensembl chr 6:99,839,960...99,843,245
G
Gria3
glutamate ionotropic receptor AMPA type subunit 3
multiple interactions
EXP
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of GRIA3 mRNA]
CTD
PMID:31068541
NCBI chr X:127,561,843...127,829,763
Ensembl chr X:127,562,660...127,829,753
G
Gsta5
glutathione S-transferase alpha 5
multiple interactions
EXP
[isoquercitrin co-treated with oxfendazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTA5 mRNA]
CTD
PMID:20033131 PMID:20045035
NCBI chr 8:85,553,659...85,564,914
Ensembl chr 8:85,553,734...85,565,179
G
Gstm1
glutathione S-transferase mu 1
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GSTM1 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA]
CTD
PMID:20033131 PMID:20045035
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of HMGCR mRNA
CTD
PMID:18032389
NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of HMGCS1 mRNA
CTD
PMID:18032389
NCBI chr 2:52,427,351...52,445,082
Ensembl chr 2:52,431,601...52,445,055
G
Hmox1
heme oxygenase 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [beta-Naphthoflavone results in increased expression of HMOX1 protein]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of HMOX1 mRNA]
CTD
PMID:21295105 PMID:30817903
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Ibsp
integrin-binding sialoprotein
increases expression
EXP
isoquercitrin results in increased expression of IBSP mRNA
CTD
PMID:30365939
NCBI chr14:6,801,200...6,813,987
Ensembl chr14:6,801,204...6,813,945
G
Il1a
interleukin 1 alpha
multiple interactions
EXP
[isoquercitrin analog co-treated with Propylthiouracil] results in increased expression of IL1A mRNA; [isoquercitrin co-treated with Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IL1A mRNA
CTD
PMID:21295105 PMID:31068541
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
G
Il1b
interleukin 1 beta
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of IL1B mRNA]
CTD
PMID:30817903
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il6
interleukin 6
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of IL6 mRNA]
CTD
PMID:30817903
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Insig1
insulin induced gene 1
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of INSIG1 mRNA
CTD
PMID:18032389
NCBI chr 4:342,302...350,515
Ensembl chr 4:342,302...350,515
G
Jak1
Janus kinase 1
increases expression
ISO
isoquercitrin results in increased expression of JAK1 mRNA
CTD
PMID:30597948
NCBI chr 5:119,982,503...120,091,452
Ensembl chr 5:119,982,943...120,083,904
G
Jak2
Janus kinase 2
increases expression
ISO
isoquercitrin results in increased expression of JAK2 mRNA
CTD
PMID:30597948
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in decreased expression of KEAP1 mRNA]
CTD
PMID:30817903
NCBI chr 8:22,250,518...22,259,868
Ensembl chr 8:22,250,518...22,259,779
G
Lct
lactase
multiple interactions
EXP
[migalastat results in decreased activity of LCT protein] which results in decreased hydrolysis of isoquercitrin
CTD
PMID:12663055
NCBI chr13:44,998,414...45,040,593
Ensembl chr13:44,998,414...45,040,593
G
Ldlr
low density lipoprotein receptor
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of LDLR mRNA
CTD
PMID:18032389
NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]
CTD
PMID:26109002
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:26109002
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
affects expression
ISO
isoquercitrin affects the expression of MCL1 mRNA
CTD
PMID:30597948
NCBI chr 2:197,786,212...197,788,992
G
Me1
malic enzyme 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of ME1 mRNA]
CTD
PMID:20033131
NCBI chr 8:94,256,830...94,368,834
Ensembl chr 8:94,256,839...94,368,834
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
isoquercitrin results in decreased expression of and results in decreased activity of MMP2 protein
CTD
PMID:18715546
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
isoquercitrin results in decreased expression of and results in decreased activity of MMP9 protein
CTD
PMID:18715546
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
Nfe2l2
nuclear factor, erythroid 2-like 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA]
CTD
PMID:30817903
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
EXP
[isoquercitrin analog co-treated with Propylthiouracil] results in decreased expression of NFKB1 mRNA
CTD
PMID:31068541
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NFKBIA mRNA]
CTD
PMID:20045035
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOS2 mRNA]
CTD
PMID:21295105
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of NQO1 mRNA; isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of NQO1 mRNA]
CTD
PMID:20033131 PMID:31068541
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
multiple interactions
EXP
[Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid co-treated with isoquercitrin analog] results in increased expression of NR3C2 mRNA
CTD
PMID:30298849
NCBI chr19:34,408,275...34,761,003
Ensembl chr19:34,448,289...34,752,695
G
Nsf
N-ethylmaleimide sensitive factor, vesicle fusing ATPase
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of NSF mRNA]
CTD
PMID:25129099
NCBI chr10:91,879,608...91,986,242
Ensembl chr10:91,878,633...92,008,082
G
Nsg1
neuronal vesicle trafficking associated 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of NSG1 mRNA]
CTD
PMID:25129099
NCBI chr14:77,380,264...77,402,007
Ensembl chr14:77,380,262...77,401,996
G
Opa1
OPA1, mitochondrial dynamin like GTPase
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of OPA1 mRNA]
CTD
PMID:25129099
NCBI chr11:74,717,600...74,793,902
Ensembl chr11:74,720,254...74,793,803
G
Otx2
orthodenticle homeobox 2
multiple interactions
EXP
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]
CTD
PMID:31068541
NCBI chr15:25,500,037...25,511,619
Ensembl chr15:25,502,019...25,505,691
G
Park7
Parkinsonism associated deglycase
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PARK7 mRNA]
CTD
PMID:25129099
NCBI chr 5:167,982,438...168,004,724
Ensembl chr 5:167,982,439...168,004,724
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
affects expression
ISO
isoquercitrin affects the expression of PIK3CA mRNA
CTD
PMID:30597948
NCBI chr 2:118,831,350...118,861,456
Ensembl chr 2:118,831,350...118,861,454
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
increases expression
ISO
isoquercitrin results in increased expression of PIK3R1 mRNA
CTD
PMID:30597948
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
G
Ppid
peptidylprolyl isomerase D
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PPID mRNA]
CTD
PMID:25129099
NCBI chr 2:178,354,830...178,366,843
Ensembl chr 2:178,354,890...178,366,685
G
Prkn
parkin RBR E3 ubiquitin protein ligase
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PRKN mRNA]
CTD
PMID:25129099
NCBI chr 1:48,880,015...50,069,998
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA]; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 protein]; isoquercitrin inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of PTGS2 mRNA]
CTD
PMID:14654164 PMID:20045035 PMID:30817903
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
G
Ptk2
protein tyrosine kinase 2
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein]
CTD
PMID:26109002
NCBI chr 7:114,436,419...114,611,317
Ensembl chr 7:114,437,361...114,590,119
G
Relb
RELB proto-oncogene, NF-kB subunit
increases expression
ISO
isoquercitrin results in increased expression of RELB mRNA
CTD
PMID:30597948
NCBI chr 1:80,517,081...80,545,019
Ensembl chr 1:80,517,411...80,544,825
G
Runx2
RUNX family transcription factor 2
increases expression
EXP
isoquercitrin results in increased expression of RUNX2 mRNA
CTD
PMID:30365939
NCBI chr 9:18,564,743...18,773,092
Ensembl chr 9:18,564,927...18,773,092
G
Sc5d
sterol-C5-desaturase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SC5D mRNA
CTD
PMID:18032389
NCBI chr 8:46,525,406...46,537,014
Ensembl chr 8:46,525,400...46,537,050
G
Serpine1
serpin family E member 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SERPINE1 mRNA]
CTD
PMID:20045035
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
G
Slc5a1
solute carrier family 5 member 1
multiple interactions
ISO
isoquercitrin inhibits the reaction [SLC5A1 protein results in increased uptake of methylglucoside]
CTD
PMID:17495124
NCBI chr14:82,910,448...82,975,303
Ensembl chr14:82,909,981...82,975,263
G
Sqle
squalene epoxidase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SQLE mRNA
CTD
PMID:18032389
NCBI chr 7:99,609,929...99,624,803
Ensembl chr 7:99,609,191...99,624,732
G
Srebf2
sterol regulatory element binding transcription factor 2
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased cleavage of and results in increased activity of SREBF2 protein; [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SREBF2 mRNA; SREBF2 protein affects the susceptibility to [isoquercitrin co-treated with Hydrogen Peroxide]
CTD
PMID:18032389
NCBI chr 7:123,381,082...123,438,605
Ensembl chr 7:123,381,077...123,438,603
G
Stat3
signal transducer and activator of transcription 3
increases expression
ISO
isoquercitrin results in increased expression of STAT3 mRNA
CTD
PMID:30597948
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Stat6
signal transducer and activator of transcription 6
increases expression
ISO
isoquercitrin results in increased expression of STAT6 mRNA
CTD
PMID:30597948
NCBI chr 7:70,946,228...70,963,542
Ensembl chr 7:70,946,228...70,964,484
G
Stub1
STIP1 homology and U-box containing protein 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of STUB1 mRNA]
CTD
PMID:25129099
NCBI chr10:15,197,754...15,200,035
Ensembl chr10:15,197,803...15,200,117
G
Th
tyrosine hydroxylase
multiple interactions
EXP
isoquercitrin promotes the reaction [Oxidopamine results in decreased expression of TH mRNA]
CTD
PMID:25129099
NCBI chr 1:216,073,034...216,080,287
Ensembl chr 1:216,073,031...216,080,287
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
ISO
isoquercitrin results in increased expression of TIMP1 protein
CTD
PMID:18715546
NCBI chr X:1,364,771...1,369,451
Ensembl chr X:1,364,786...1,369,384
G
Tnf
tumor necrosis factor
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TNF mRNA]; isoquercitrin inhibits the reaction [Carrageenan results in increased expression of TNF protein]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of TNF mRNA]
CTD
PMID:14654164 PMID:21295105 PMID:30817903
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tnfrsf1a
TNF receptor superfamily member 1A
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TNFRSF1A protein]
CTD
PMID:21295105
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
G
Tp53
tumor protein p53
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of TP53 mRNA]
CTD
PMID:30817903
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Tradd
TNFRSF1A-associated via death domain
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TRADD protein]
CTD
PMID:21295105
NCBI chr19:37,214,461...37,221,099
Ensembl chr19:37,214,471...37,216,572
G
Txn1
thioredoxin 1
multiple interactions
EXP
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of TXN1 mRNA]
CTD
PMID:31068541
NCBI chr 5:75,049,735...75,057,731
Ensembl chr 5:75,049,747...75,057,752
G
Tyk2
tyrosine kinase 2
affects expression
ISO
isoquercitrin affects the expression of TYK2 mRNA
CTD
PMID:30597948
NCBI chr 8:22,118,224...22,149,807
Ensembl chr 8:22,124,560...22,150,005
G
Uchl1
ubiquitin C-terminal hydrolase L1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of UCHL1 mRNA]
CTD
PMID:25129099
NCBI chr14:43,133,224...43,143,942
Ensembl chr14:43,133,218...43,143,973
G
Acat2
acetyl-CoA acetyltransferase 2
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of ACAT2 mRNA
CTD
PMID:18032389
NCBI chr 1:47,972,399...47,992,654
Ensembl chr 1:47,972,399...47,992,653
G
Akr7a3
aldo-keto reductase family 7 member A3
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of AKR7A3 mRNA
CTD
PMID:20033131
NCBI chr 5:157,801,120...157,813,756
Ensembl chr 5:157,801,163...157,813,756
G
Apoa1
apolipoprotein A1
increases secretion
ISO
isoquercitrin results in increased secretion of APOA1 protein
CTD
PMID:24963805
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
G
Atf6
activating transcription factor 6
increases expression
EXP
isoquercitrin results in increased expression of ATF6 mRNA
CTD
PMID:30365939
NCBI chr13:89,053,457...89,242,531
Ensembl chr13:89,055,983...89,242,443
G
Atxn2
ataxin 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of ATXN2 mRNA]
CTD
PMID:25129099
NCBI chr12:40,264,601...40,335,637
Ensembl chr12:40,266,662...40,332,612
G
Atxn3
ataxin 3
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of ATXN3 mRNA]
CTD
PMID:25129099
NCBI chr 6:125,817,420...125,853,461
Ensembl chr 6:125,819,640...125,853,461
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
isoquercitrin results in decreased expression of BCL2 mRNA
CTD
PMID:30597948
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Casp3
caspase 3
affects expression
ISO
isoquercitrin affects the expression of CASP3 mRNA
CTD
PMID:30597948
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Casp8
caspase 8
decreases expression
ISO
isoquercitrin results in decreased expression of CASP8 mRNA
CTD
PMID:30597948
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
G
Cat
catalase
multiple interactions
EXP
[Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid co-treated with isoquercitrin analog] results in increased expression of CAT mRNA; isoquercitrin inhibits the reaction [Streptozocin results in decreased activity of CAT protein]
CTD
PMID:30298849 PMID:30817903
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA]
CTD
PMID:21295105
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
EXP
isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein]
CTD
PMID:14654164
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA]
CTD
PMID:21295105
NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
G
Ctnnb1
catenin beta 1
affects expression
ISO
isoquercitrin affects the expression of CTNNB1 mRNA
CTD
PMID:30597948
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CXCL2 protein]
CTD
PMID:14654164
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity multiple interactions
ISO EXP
isoquercitrin results in decreased activity of CYP1A1 protein [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A1 mRNA
CTD
PMID:16271822 PMID:20033131
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA
CTD
PMID:20033131
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
isoquercitrin results in decreased activity of CYP1B1 protein
CTD
PMID:16271822
NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of CYP2B2 mRNA]
CTD
PMID:20033131
NCBI chr 1:83,103,925...83,119,578
Ensembl chr 1:83,103,925...83,119,193
G
Cyp51
cytochrome P450, family 51
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of CYP51A1 mRNA
CTD
PMID:18032389
NCBI chr 4:27,175,564...27,194,018
Ensembl chr 4:27,175,243...27,194,018
G
Dhcr7
7-dehydrocholesterol reductase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of DHCR7 mRNA
CTD
PMID:18032389
NCBI chr 1:217,018,916...217,034,890
Ensembl chr 1:217,018,916...217,034,904
G
Egf
epidermal growth factor
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein]
CTD
PMID:26109002
NCBI chr 2:68,820,616...68,895,537
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]
CTD
PMID:26109002
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
G
Egln1
egl-9 family hypoxia-inducible factor 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of EGLN1 mRNA]
CTD
PMID:25129099
NCBI chr19:57,660,194...57,701,158
Ensembl chr19:57,662,278...57,699,113
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of FDFT1 mRNA
CTD
PMID:18032389
NCBI chr15:46,339,248...46,367,302
Ensembl chr15:46,339,249...46,367,302
G
Fdps
farnesyl diphosphate synthase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of FDPS mRNA
CTD
PMID:18032389
NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
[isoquercitrin analog co-treated with Propylthiouracil] results in decreased expression of FOS mRNA
CTD
PMID:31068541
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Gpx2
glutathione peroxidase 2
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GPX2 mRNA
CTD
PMID:20033131
NCBI chr 6:99,839,960...99,843,245
Ensembl chr 6:99,839,960...99,843,245
G
Gria3
glutamate ionotropic receptor AMPA type subunit 3
multiple interactions
EXP
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of GRIA3 mRNA]
CTD
PMID:31068541
NCBI chr X:127,561,843...127,829,763
Ensembl chr X:127,562,660...127,829,753
G
Gsta5
glutathione S-transferase alpha 5
multiple interactions
EXP
[isoquercitrin co-treated with oxfendazole co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTA5 mRNA]
CTD
PMID:20033131 PMID:20045035
NCBI chr 8:85,553,659...85,564,914
Ensembl chr 8:85,553,734...85,565,179
G
Gstm1
glutathione S-transferase mu 1
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GSTM1 mRNA; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA]
CTD
PMID:20033131 PMID:20045035
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of HMGCR mRNA
CTD
PMID:18032389
NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of HMGCS1 mRNA
CTD
PMID:18032389
NCBI chr 2:52,427,351...52,445,082
Ensembl chr 2:52,431,601...52,445,055
G
Hmox1
heme oxygenase 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [beta-Naphthoflavone results in increased expression of HMOX1 protein]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of HMOX1 mRNA]
CTD
PMID:21295105 PMID:30817903
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Ibsp
integrin-binding sialoprotein
increases expression
EXP
isoquercitrin results in increased expression of IBSP mRNA
CTD
PMID:30365939
NCBI chr14:6,801,200...6,813,987
Ensembl chr14:6,801,204...6,813,945
G
Il1a
interleukin 1 alpha
multiple interactions
EXP
[isoquercitrin analog co-treated with Propylthiouracil] results in increased expression of IL1A mRNA; [isoquercitrin co-treated with Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IL1A mRNA
CTD
PMID:21295105 PMID:31068541
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
G
Il1b
interleukin 1 beta
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of IL1B mRNA]
CTD
PMID:30817903
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il6
interleukin 6
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of IL6 mRNA]
CTD
PMID:30817903
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Insig1
insulin induced gene 1
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of INSIG1 mRNA
CTD
PMID:18032389
NCBI chr 4:342,302...350,515
Ensembl chr 4:342,302...350,515
G
Jak1
Janus kinase 1
increases expression
ISO
isoquercitrin results in increased expression of JAK1 mRNA
CTD
PMID:30597948
NCBI chr 5:119,982,503...120,091,452
Ensembl chr 5:119,982,943...120,083,904
G
Jak2
Janus kinase 2
increases expression
ISO
isoquercitrin results in increased expression of JAK2 mRNA
CTD
PMID:30597948
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in decreased expression of KEAP1 mRNA]
CTD
PMID:30817903
NCBI chr 8:22,250,518...22,259,868
Ensembl chr 8:22,250,518...22,259,779
G
Lct
lactase
multiple interactions
EXP
[migalastat results in decreased activity of LCT protein] which results in decreased hydrolysis of isoquercitrin
CTD
PMID:12663055
NCBI chr13:44,998,414...45,040,593
Ensembl chr13:44,998,414...45,040,593
G
Ldlr
low density lipoprotein receptor
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of LDLR mRNA
CTD
PMID:18032389
NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]
CTD
PMID:26109002
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:26109002
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
affects expression
ISO
isoquercitrin affects the expression of MCL1 mRNA
CTD
PMID:30597948
NCBI chr 2:197,786,212...197,788,992
G
Me1
malic enzyme 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of ME1 mRNA]
CTD
PMID:20033131
NCBI chr 8:94,256,830...94,368,834
Ensembl chr 8:94,256,839...94,368,834
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
isoquercitrin results in decreased expression of and results in decreased activity of MMP2 protein
CTD
PMID:18715546
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
isoquercitrin results in decreased expression of and results in decreased activity of MMP9 protein
CTD
PMID:18715546
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
Nfe2l2
nuclear factor, erythroid 2-like 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA]
CTD
PMID:30817903
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
EXP
[isoquercitrin analog co-treated with Propylthiouracil] results in decreased expression of NFKB1 mRNA
CTD
PMID:31068541
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NFKBIA mRNA]
CTD
PMID:20045035
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOS2 mRNA]
CTD
PMID:21295105
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
[Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of NQO1 mRNA; isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of NQO1 mRNA]
CTD
PMID:20033131 PMID:31068541
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
multiple interactions
EXP
[Diethylnitrosamine co-treated with Dietary Fats co-treated with Canrenoic Acid co-treated with isoquercitrin analog] results in increased expression of NR3C2 mRNA
CTD
PMID:30298849
NCBI chr19:34,408,275...34,761,003
Ensembl chr19:34,448,289...34,752,695
G
Nsf
N-ethylmaleimide sensitive factor, vesicle fusing ATPase
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of NSF mRNA]
CTD
PMID:25129099
NCBI chr10:91,879,608...91,986,242
Ensembl chr10:91,878,633...92,008,082
G
Nsg1
neuronal vesicle trafficking associated 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of NSG1 mRNA]
CTD
PMID:25129099
NCBI chr14:77,380,264...77,402,007
Ensembl chr14:77,380,262...77,401,996
G
Opa1
OPA1, mitochondrial dynamin like GTPase
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in decreased expression of OPA1 mRNA]
CTD
PMID:25129099
NCBI chr11:74,717,600...74,793,902
Ensembl chr11:74,720,254...74,793,803
G
Otx2
orthodenticle homeobox 2
multiple interactions
EXP
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]
CTD
PMID:31068541
NCBI chr15:25,500,037...25,511,619
Ensembl chr15:25,502,019...25,505,691
G
Park7
Parkinsonism associated deglycase
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PARK7 mRNA]
CTD
PMID:25129099
NCBI chr 5:167,982,438...168,004,724
Ensembl chr 5:167,982,439...168,004,724
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
affects expression
ISO
isoquercitrin affects the expression of PIK3CA mRNA
CTD
PMID:30597948
NCBI chr 2:118,831,350...118,861,456
Ensembl chr 2:118,831,350...118,861,454
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
increases expression
ISO
isoquercitrin results in increased expression of PIK3R1 mRNA
CTD
PMID:30597948
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
G
Ppid
peptidylprolyl isomerase D
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PPID mRNA]
CTD
PMID:25129099
NCBI chr 2:178,354,830...178,366,843
Ensembl chr 2:178,354,890...178,366,685
G
Prkn
parkin RBR E3 ubiquitin protein ligase
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PRKN mRNA]
CTD
PMID:25129099
NCBI chr 1:48,880,015...50,069,998
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA]; isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 protein]; isoquercitrin inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of PTGS2 mRNA]
CTD
PMID:14654164 PMID:20045035 PMID:30817903
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
G
Ptk2
protein tyrosine kinase 2
multiple interactions
ISO
isoquercitrin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein]
CTD
PMID:26109002
NCBI chr 7:114,436,419...114,611,317
Ensembl chr 7:114,437,361...114,590,119
G
Relb
RELB proto-oncogene, NF-kB subunit
increases expression
ISO
isoquercitrin results in increased expression of RELB mRNA
CTD
PMID:30597948
NCBI chr 1:80,517,081...80,545,019
Ensembl chr 1:80,517,411...80,544,825
G
Runx2
RUNX family transcription factor 2
increases expression
EXP
isoquercitrin results in increased expression of RUNX2 mRNA
CTD
PMID:30365939
NCBI chr 9:18,564,743...18,773,092
Ensembl chr 9:18,564,927...18,773,092
G
Sc5d
sterol-C5-desaturase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SC5D mRNA
CTD
PMID:18032389
NCBI chr 8:46,525,406...46,537,014
Ensembl chr 8:46,525,400...46,537,050
G
Serpine1
serpin family E member 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SERPINE1 mRNA]
CTD
PMID:20045035
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
G
Slc5a1
solute carrier family 5 member 1
multiple interactions
ISO
isoquercitrin inhibits the reaction [SLC5A1 protein results in increased uptake of methylglucoside]
CTD
PMID:17495124
NCBI chr14:82,910,448...82,975,303
Ensembl chr14:82,909,981...82,975,263
G
Sqle
squalene epoxidase
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SQLE mRNA
CTD
PMID:18032389
NCBI chr 7:99,609,929...99,624,803
Ensembl chr 7:99,609,191...99,624,732
G
Srebf2
sterol regulatory element binding transcription factor 2
multiple interactions
ISO
[isoquercitrin co-treated with Hydrogen Peroxide] results in increased cleavage of and results in increased activity of SREBF2 protein; [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of SREBF2 mRNA; SREBF2 protein affects the susceptibility to [isoquercitrin co-treated with Hydrogen Peroxide]
CTD
PMID:18032389
NCBI chr 7:123,381,082...123,438,605
Ensembl chr 7:123,381,077...123,438,603
G
Stat3
signal transducer and activator of transcription 3
increases expression
ISO
isoquercitrin results in increased expression of STAT3 mRNA
CTD
PMID:30597948
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Stat6
signal transducer and activator of transcription 6
increases expression
ISO
isoquercitrin results in increased expression of STAT6 mRNA
CTD
PMID:30597948
NCBI chr 7:70,946,228...70,963,542
Ensembl chr 7:70,946,228...70,964,484
G
Stub1
STIP1 homology and U-box containing protein 1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of STUB1 mRNA]
CTD
PMID:25129099
NCBI chr10:15,197,754...15,200,035
Ensembl chr10:15,197,803...15,200,117
G
Th
tyrosine hydroxylase
multiple interactions
EXP
isoquercitrin promotes the reaction [Oxidopamine results in decreased expression of TH mRNA]
CTD
PMID:25129099
NCBI chr 1:216,073,034...216,080,287
Ensembl chr 1:216,073,031...216,080,287
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
ISO
isoquercitrin results in increased expression of TIMP1 protein
CTD
PMID:18715546
NCBI chr X:1,364,771...1,369,451
Ensembl chr X:1,364,786...1,369,384
G
Tnf
tumor necrosis factor
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TNF mRNA]; isoquercitrin inhibits the reaction [Carrageenan results in increased expression of TNF protein]; isoquercitrin inhibits the reaction [Streptozocin results in increased expression of TNF mRNA]
CTD
PMID:14654164 PMID:21295105 PMID:30817903
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tnfrsf1a
TNF receptor superfamily member 1A
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TNFRSF1A protein]
CTD
PMID:21295105
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
G
Tp53
tumor protein p53
multiple interactions
EXP
isoquercitrin inhibits the reaction [Streptozocin results in increased expression of TP53 mRNA]
CTD
PMID:30817903
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Tradd
TNFRSF1A-associated via death domain
multiple interactions
EXP
isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TRADD protein]
CTD
PMID:21295105
NCBI chr19:37,214,461...37,221,099
Ensembl chr19:37,214,471...37,216,572
G
Txn1
thioredoxin 1
multiple interactions
EXP
isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of TXN1 mRNA]
CTD
PMID:31068541
NCBI chr 5:75,049,735...75,057,731
Ensembl chr 5:75,049,747...75,057,752
G
Tyk2
tyrosine kinase 2
affects expression
ISO
isoquercitrin affects the expression of TYK2 mRNA
CTD
PMID:30597948
NCBI chr 8:22,118,224...22,149,807
Ensembl chr 8:22,124,560...22,150,005
G
Uchl1
ubiquitin C-terminal hydrolase L1
multiple interactions
EXP
isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of UCHL1 mRNA]
CTD
PMID:25129099
NCBI chr14:43,133,224...43,143,942
Ensembl chr14:43,133,218...43,143,973
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; spiraeoside inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]
CTD
PMID:32602595
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in increased expression of BAX protein]]; spiraeoside inhibits the reaction [Glucose results in increased expression of BAX protein]
CTD
PMID:32602595
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]
CTD
PMID:32602595
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Cat
catalase
multiple interactions
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in increased activity of CAT protein]]; spiraeoside inhibits the reaction [Glucose results in increased activity of CAT protein]
CTD
PMID:32602595
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
G
Cryz
crystallin zeta
increases activity
ISO
spiraeoside results in increased activity of CRYZ protein
CTD
PMID:8968052
NCBI chr 2:260,884,315...260,911,827
Ensembl chr 2:260,884,337...260,911,792
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]]; spiraeoside inhibits the reaction [Glucose results in decreased expression of HMOX1 protein]
CTD
PMID:32602595
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Lct
lactase
multiple interactions
EXP
[migalastat results in decreased activity of LCT protein] which results in decreased hydrolysis of spiraeoside
CTD
PMID:12663055
NCBI chr13:44,998,414...45,040,593
Ensembl chr13:44,998,414...45,040,593
G
Nfe2l2
nuclear factor, erythroid 2-like 2
multiple interactions
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]]; spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]
CTD
PMID:32602595
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
G
Plcg2
phospholipase C, gamma 2
decreases phosphorylation
ISO
spiraeoside results in decreased phosphorylation of PLCG2 protein
CTD
PMID:15613018
NCBI chr19:50,039,410...50,173,543
Ensembl chr19:50,045,020...50,173,220
G
Slc5a1
solute carrier family 5 member 1
multiple interactions
EXP ISO
[Phlorhizin results in decreased activity of SLC5A1 protein] which results in decreased uptake of spiraeoside spiraeoside inhibits the reaction [SLC5A1 protein results in increased uptake of methylglucoside]
CTD
PMID:12663055 PMID:17495124
NCBI chr14:82,910,448...82,975,303
Ensembl chr14:82,909,981...82,975,263
G
Syk
spleen associated tyrosine kinase
decreases phosphorylation
ISO
spiraeoside results in decreased phosphorylation of SYK protein
CTD
PMID:15613018
NCBI chr17:12,614,311...12,669,568
Ensembl chr17:12,614,311...12,669,573
G
Abcc4
ATP binding cassette subfamily C member 4
decreases expression
ISO
quercitrin results in decreased expression of ABCC4 mRNA
CTD
PMID:25193878
NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592
G
Abcf2
ATP binding cassette subfamily F member 2
increases expression
ISO
quercitrin results in increased expression of ABCF2 mRNA
CTD
PMID:25193878
NCBI chr 4:7,122,850...7,135,607
Ensembl chr 4:7,122,890...7,135,669
G
Acbd6
acyl-CoA binding domain containing 6
decreases expression
ISO
quercitrin results in decreased expression of ACBD6 mRNA
CTD
PMID:25193878
NCBI chr13:73,196,504...73,334,077
Ensembl chr13:73,196,571...73,334,077
G
Acbd7
acyl-CoA binding domain containing 7
increases expression
ISO
quercitrin results in increased expression of ACBD7 mRNA
CTD
PMID:25193878
NCBI chr17:78,904,549...78,913,372
Ensembl chr17:78,904,873...78,910,671
G
Actn1
actinin, alpha 1
affects expression
ISO
quercitrin affects the expression of ACTN1 mRNA
CTD
PMID:25193878
NCBI chr 6:103,376,557...103,470,497
Ensembl chr 6:103,375,799...103,470,555
G
Actn4
actinin alpha 4
affects expression
ISO
quercitrin affects the expression of ACTN4 mRNA
CTD
PMID:25193878
NCBI chr 1:87,078,012...87,147,347
Ensembl chr 1:87,078,020...87,147,333
G
Adgrb1
adhesion G protein-coupled receptor B1
decreases expression
ISO
quercitrin results in decreased expression of ADGRB1 mRNA
CTD
PMID:25193878
NCBI chr 7:115,766,484...115,828,514
G
Adgrf1
adhesion G protein-coupled receptor F1
decreases expression
ISO
quercitrin results in decreased expression of ADGRF1 mRNA
CTD
PMID:25193878
NCBI chr 9:20,343,730...20,378,686
G
Adgrg1
adhesion G protein-coupled receptor G1
decreases expression
ISO
quercitrin results in decreased expression of ADGRG1 mRNA
CTD
PMID:25193878
NCBI chr19:10,423,534...10,460,674
Ensembl chr19:10,423,501...10,460,674
G
Adgrg6
adhesion G protein-coupled receptor G6
decreases expression
ISO
quercitrin results in decreased expression of ADGRG6 mRNA
CTD
PMID:25193878
NCBI chr 1:8,593,342...8,751,540
Ensembl chr 1:8,593,075...8,751,198
G
Adgrg7
adhesion G protein-coupled receptor G7
increases expression
ISO
quercitrin results in increased expression of ADGRG7 mRNA
CTD
PMID:25193878
NCBI chr11:46,103,173...46,172,303
Ensembl chr11:46,793,777...46,856,291 Ensembl chr11:46,793,777...46,856,291
G
Adgrv1
adhesion G protein-coupled receptor V1
increases expression
ISO
quercitrin results in increased expression of ADGRV1 mRNA
CTD
PMID:25193878
NCBI chr 2:8,926,843...9,504,455
Ensembl chr 2:8,926,850...9,504,134
G
Adk
adenosine kinase
decreases expression
ISO
quercitrin results in decreased expression of ADK mRNA
CTD
PMID:25193878
NCBI chr15:3,033,535...3,435,888
Ensembl chr15:3,033,495...3,435,888
G
Adra2c
adrenoceptor alpha 2C
increases expression
ISO
quercitrin results in increased expression of ADRA2C mRNA
CTD
PMID:25193878
NCBI chr14:80,730,307...80,732,010
Ensembl chr14:80,730,307...80,732,010
G
Ahnak2
AHNAK nucleoprotein 2
increases expression
ISO
quercitrin results in increased expression of AHNAK2 mRNA
CTD
PMID:25193878
NCBI chr 6:137,335,273...137,380,219
G
Alkbh7
alkB homolog 7
increases expression
ISO
quercitrin results in increased expression of ALKBH7 mRNA
CTD
PMID:25193878
NCBI chr 9:10,045,375...10,047,507
Ensembl chr 9:10,045,375...10,047,507
G
Anapc15
anaphase promoting complex subunit 15
decreases expression
ISO
quercitrin results in decreased expression of ANAPC15 mRNA
CTD
PMID:25193878
NCBI chr 1:166,981,738...166,985,363
Ensembl chr 1:166,983,175...166,985,054
G
Ar
androgen receptor
increases expression
ISO
quercitrin results in increased expression of AR mRNA
CTD
PMID:25193878
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
G
Arap2
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
increases expression
ISO
quercitrin results in increased expression of ARAP2 mRNA
CTD
PMID:25193878
NCBI chr14:48,726,033...48,922,809
Ensembl chr14:48,726,045...48,922,983
G
Asb6
ankyrin repeat and SOCS box-containing 6
increases expression
ISO
quercitrin results in increased expression of ASB6 mRNA
CTD
PMID:25193878
NCBI chr 3:9,659,707...9,664,445
Ensembl chr 3:9,659,710...9,664,318
G
Atg7
autophagy related 7
decreases expression
ISO
quercitrin results in decreased expression of ATG7 mRNA
CTD
PMID:25193878
NCBI chr 4:146,570,113...146,777,093
Ensembl chr 4:146,598,413...146,777,124
G
Baiap2
BAR/IMD domain containing adaptor protein 2
affects expression
ISO
quercitrin affects the expression of BAIAP2 mRNA
CTD
PMID:25193878
NCBI chr10:109,107,326...109,187,458
Ensembl chr10:109,107,389...109,187,115
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of BAX protein]
CTD
PMID:23138875
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bdkrb1
bradykinin receptor B1
decreases expression
ISO
quercitrin results in decreased expression of BDKRB1 mRNA
CTD
PMID:25193878
NCBI chr 6:129,437,423...129,441,553
Ensembl chr 6:129,438,158...129,440,574
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
decreases expression
ISO
quercitrin results in decreased expression of CAMK2B mRNA
CTD
PMID:25193878
NCBI chr14:86,208,876...86,297,727
Ensembl chr14:86,208,901...86,297,652
G
Casp3
caspase 3
increases activity multiple interactions
ISO EXP
quercitrin results in increased activity of CASP3 protein quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of CASP3 protein]
CTD
PMID:23138875 PMID:25193878
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Casp8
caspase 8
increases expression
ISO
quercitrin results in increased expression of CASP8 mRNA
CTD
PMID:25193878
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
G
Ccr9
C-C motif chemokine receptor 9
decreases expression
ISO
quercitrin results in decreased expression of CCR9 mRNA
CTD
PMID:25193878
NCBI chr 8:132,827,325...132,842,130
Ensembl chr 8:132,828,091...132,842,130
G
Ccrl2
C-C motif chemokine receptor like 2
increases expression
ISO
quercitrin results in increased expression of CCRL2 mRNA
CTD
PMID:25193878
NCBI chr 8:119,324,298...119,326,954
Ensembl chr 8:119,324,613...119,326,938
G
Cd302
CD302 molecule
decreases expression
ISO
quercitrin results in decreased expression of CD302 mRNA
CTD
PMID:25193878
NCBI chr 3:46,327,382...46,361,092
Ensembl chr 3:46,327,383...46,361,092
G
Cd38
CD38 molecule
decreases expression
ISO
quercitrin results in decreased expression of CD38 mRNA
CTD
PMID:25193878
NCBI chr14:71,714,768...71,754,990
Ensembl chr14:71,715,269...71,754,672
G
Cd74
CD74 molecule
affects expression
ISO
quercitrin affects the expression of CD74 mRNA
CTD
PMID:25193878
NCBI chr18:56,071,420...56,080,851
Ensembl chr18:56,071,478...56,080,849
G
Cdh1
cadherin 1
decreases expression
ISO
quercitrin results in decreased expression of CDH1 mRNA
CTD
PMID:25193878
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
G
Cdkn3
cyclin-dependent kinase inhibitor 3
decreases expression
ISO
quercitrin results in decreased expression of CDKN3 mRNA
CTD
PMID:25193878
NCBI chr15:23,553,171...23,564,538
Ensembl chr15:23,553,128...23,564,535
G
Celsr3
cadherin, EGF LAG seven-pass G-type receptor 3
increases expression
ISO
quercitrin results in increased expression of CELSR3 mRNA
CTD
PMID:25193878
NCBI chr 8:117,620,293...117,648,034
Ensembl chr 8:117,620,317...117,648,028
G
Cep95
centrosomal protein 95
increases expression
ISO
quercitrin results in increased expression of CEP95 mRNA
CTD
PMID:25193878
NCBI chr10:94,988,362...95,017,774
Ensembl chr10:94,988,362...95,016,344
G
Cers5
ceramide synthase 5
increases expression
ISO
quercitrin results in increased expression of CERS5 mRNA
CTD
PMID:25193878
NCBI chr 7:141,386,391...141,424,375
Ensembl chr 7:141,386,391...141,424,343
G
Cfap298
cilia and flagella associated protein 298
decreases expression
ISO
quercitrin results in decreased expression of CFAP298 mRNA
CTD
PMID:25193878
NCBI chr11:31,094,103...31,103,487
Ensembl chr11:31,094,084...31,103,520
G
Chd2
chromodomain helicase DNA binding protein 2
decreases expression
ISO
quercitrin results in decreased expression of CHD2 mRNA
CTD
PMID:25193878
NCBI chr 1:134,757,934...134,873,053
Ensembl chr 1:134,757,934...134,871,167
G
Cldn10
claudin 10
affects expression
ISO
quercitrin affects the expression of CLDN10 mRNA
CTD
PMID:25193878
NCBI chr15:104,026,590...104,115,748
Ensembl chr15:104,026,601...104,115,748
G
Cldn23
claudin 23
affects expression
ISO
quercitrin affects the expression of CLDN23 mRNA
CTD
PMID:25193878
NCBI chr16:59,988,603...59,990,327
Ensembl chr16:59,988,603...59,990,326
G
Cldn4
claudin 4
affects expression
ISO
quercitrin affects the expression of CLDN4 mRNA
CTD
PMID:25193878
NCBI chr12:24,761,210...24,763,008
Ensembl chr12:24,761,210...24,763,005
G
Cldn8
claudin 8
affects expression
ISO
quercitrin affects the expression of CLDN8 mRNA
CTD
PMID:25193878
NCBI chr11:28,525,641...28,527,890
Ensembl chr11:28,525,643...28,527,890
G
Col3a1
collagen type III alpha 1 chain
decreases expression
ISO
quercitrin results in decreased expression of COL3A1 mRNA
CTD
PMID:25193878
NCBI chr 9:52,023,295...52,059,221
Ensembl chr 9:52,023,295...52,059,217
G
Coq3
coenzyme Q3 methyltransferase
decreases expression
ISO
quercitrin results in decreased expression of COQ3 mRNA
CTD
PMID:25193878
NCBI chr 5:36,024,673...36,056,664
Ensembl chr 5:36,024,649...36,056,669
G
Crisp1
cysteine-rich secretory protein 1
decreases expression
ISO
quercitrin results in decreased expression of CRISP1 mRNA
CTD
PMID:25193878
NCBI chr 9:24,356,577...24,383,679
Ensembl chr 9:24,356,579...24,383,679
G
Cryzl1
crystallin zeta like 1
decreases expression
ISO
quercitrin results in decreased expression of CRYZL1 mRNA
CTD
PMID:25193878
NCBI chr11:31,847,741...31,893,042
Ensembl chr11:31,847,745...31,892,531
G
Csnk2a1
casein kinase 2 alpha 1
affects expression
ISO
quercitrin affects the expression of CSNK2A1 mRNA
CTD
PMID:25193878
NCBI chr 3:147,713,808...147,760,375
Ensembl chr 3:147,713,821...147,757,862
G
Csnk2a2
casein kinase 2 alpha 2
affects expression
ISO
quercitrin affects the expression of CSNK2A2 mRNA
CTD
PMID:25193878
NCBI chr19:9,972,537...10,012,043
Ensembl chr19:9,972,537...10,012,043
G
Ctdspl2
CTD small phosphatase like 2
decreases expression
ISO
quercitrin results in decreased expression of CTDSPL2 mRNA
CTD
PMID:25193878
NCBI chr 3:113,906,803...113,957,289
Ensembl chr 3:113,918,629...113,960,101
G
Ctsb
cathepsin B
affects expression
ISO
quercitrin affects the expression of CTSB mRNA
CTD
PMID:25193878
NCBI chr15:46,316,741...46,337,613
Ensembl chr15:46,316,741...46,337,612
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity
ISO
quercitrin results in decreased activity of CYP1A1 protein
CTD
PMID:16271822
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
quercitrin results in decreased activity of CYP1B1 protein
CTD
PMID:16271822
NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
G
Cyp26b1
cytochrome P450, family 26, subfamily b, polypeptide 1
increases expression
ISO
quercitrin results in increased expression of CYP26B1 mRNA
CTD
PMID:25193878
NCBI chr 4:116,261,796...116,278,615
Ensembl chr 4:116,261,796...116,278,615
G
Dcun1d5
defective in cullin neddylation 1 domain containing 5
decreases expression
ISO
quercitrin results in decreased expression of DCUN1D5 mRNA
CTD
PMID:25193878
NCBI chr 8:5,437,071...5,458,152
Ensembl chr 8:5,437,071...5,458,152
G
Ddx19b
DEAD-box helicase 19B
decreases expression
ISO
quercitrin results in decreased expression of DDX19B mRNA
CTD
PMID:25193878
NCBI chr19:43,217,199...43,246,196
Ensembl chr19:43,217,161...43,275,287
G
Dele1
DAP3 binding cell death enhancer 1
decreases expression
ISO
quercitrin results in decreased expression of DELE1 mRNA
CTD
PMID:25193878
NCBI chr18:31,396,897...31,409,914
Ensembl chr18:31,396,922...31,409,907
G
Dgkq
diacylglycerol kinase, theta
affects expression
ISO
quercitrin affects the expression of DGKQ mRNA
CTD
PMID:25193878
NCBI chr14:2,069,409...2,083,370
Ensembl chr14:2,069,409...2,083,370
G
Dhrs11
dehydrogenase/reductase 11
decreases activity
ISO
quercitrin results in decreased activity of DHRS11 protein
CTD
PMID:30926317
NCBI chr10:72,144,042...72,153,496
Ensembl chr10:72,144,042...72,153,375
G
Dtwd1
DTW domain containing 1
decreases expression
ISO
quercitrin results in decreased expression of DTWD1 mRNA
CTD
PMID:25193878
NCBI chr 3:118,427,790...118,443,003
Ensembl chr 3:118,430,511...118,442,098
G
Egr2
early growth response 2
increases expression
ISO
quercitrin results in increased expression of EGR2 mRNA
CTD
PMID:25193878
NCBI chr20:22,452,170...22,461,018
Ensembl chr20:22,454,463...22,459,025
G
Epas1
endothelial PAS domain protein 1
increases expression
ISO
quercitrin results in increased expression of EPAS1 mRNA
CTD
PMID:25193878
NCBI chr 6:10,306,508...10,385,239
Ensembl chr 6:10,306,405...10,387,265
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
decreases expression
ISO
quercitrin results in decreased expression of ERCC1 mRNA
CTD
PMID:25193878
NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198
G
Ercc2
ERCC excision repair 2, TFIIH core complex helicase subunit
decreases expression
ISO
quercitrin results in decreased expression of ERCC2 mRNA
CTD
PMID:25193878
NCBI chr 1:80,293,574...80,307,334
Ensembl chr 1:80,293,566...80,307,344
G
Eri2
ERI1 exoribonuclease family member 2
increases expression
ISO
quercitrin results in increased expression of ERI2 mRNA
CTD
PMID:25193878
NCBI chr 1:189,540,145...189,549,891
Ensembl chr 1:189,540,145...189,549,891
G
Eva1a
eva-1 homolog A, regulator of programmed cell death
decreases expression
ISO
quercitrin results in decreased expression of EVA1A mRNA
CTD
PMID:25193878
NCBI chr 4:112,714,023...112,823,659
Ensembl chr 4:112,773,938...112,823,659
G
F11r
F11 receptor
affects expression
ISO
quercitrin affects the expression of F11R mRNA
CTD
PMID:25193878
NCBI chr13:89,826,272...89,850,151
Ensembl chr13:89,826,254...89,850,612
G
F2rl1
F2R like trypsin receptor 1
increases expression
ISO
quercitrin results in increased expression of F2RL1 mRNA
CTD
PMID:25193878
NCBI chr 2:25,222,324...25,235,275
Ensembl chr 2:25,222,328...25,235,275
G
F2rl2
coagulation factor II (thrombin) receptor-like 2
decreases expression
ISO
quercitrin results in decreased expression of F2RL2 mRNA
CTD
PMID:25193878
NCBI chr 2:26,240,385...26,245,533
Ensembl chr 2:26,240,385...26,245,533
G
F3
coagulation factor III, tissue factor
increases expression
ISO
quercitrin results in increased expression of F3 mRNA
CTD
PMID:25193878
NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
G
Faim
Fas apoptotic inhibitory molecule
increases expression
ISO
quercitrin results in increased expression of FAIM mRNA
CTD
PMID:25193878
NCBI chr 8:107,225,119...107,247,228
Ensembl chr 8:107,225,212...107,241,224 Ensembl chr 8:107,225,212...107,241,224
G
Fam102a
family with sequence similarity 102, member A
increases expression
ISO
quercitrin results in increased expression of FAM102A mRNA
CTD
PMID:25193878
NCBI chr 3:11,554,084...11,586,315
Ensembl chr 3:11,554,457...11,586,303
G
Fam216a
family with sequence similarity 216, member A
decreases expression
ISO
quercitrin results in decreased expression of FAM216A mRNA
CTD
PMID:25193878
NCBI chr12:39,679,688...39,688,831
Ensembl chr12:39,679,688...39,688,823
G
Fam3c
FAM3 metabolism regulating signaling molecule C
increases expression
ISO
quercitrin results in increased expression of FAM3C mRNA
CTD
PMID:25193878
NCBI chr 4:49,388,962...49,439,892
Ensembl chr 4:49,387,989...49,439,867
G
Fam43a
family with sequence similarity 43, member A
increases expression
ISO
quercitrin results in increased expression of FAM43A mRNA
CTD
PMID:25193878
NCBI chr11:73,676,601...73,679,003
Ensembl chr11:73,676,601...73,678,984
G
Fam50a
family with sequence similarity 50, member A
increases expression
ISO
quercitrin results in increased expression of FAM50A mRNA
CTD
PMID:25193878
NCBI chr X:156,392,646...156,399,763
Ensembl chr X:156,392,630...156,399,760
G
Fas
Fas cell surface death receptor
increases expression
ISO
quercitrin results in increased expression of FAS mRNA
CTD
PMID:25193878
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
G
Fdcsp
follicular dendritic cell secreted protein
decreases expression
ISO
quercitrin results in decreased expression of FDCSP mRNA
CTD
PMID:25193878
NCBI chr14:21,818,999...21,823,687
Ensembl chr14:21,819,395...21,823,687
G
Flg
filaggrin
increases expression
ISO
quercitrin results in increased expression of FLG mRNA
CTD
PMID:25193878
NCBI chr 2:193,565,401...193,574,297
G
Fzd4
frizzled class receptor 4
increases expression
ISO
quercitrin results in increased expression of FZD4 mRNA
CTD
PMID:25193878
NCBI chr 1:153,589,471...153,598,376
Ensembl chr 1:153,589,471...153,598,375
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
increases expression
ISO
quercitrin results in increased expression of GABBR2 mRNA
CTD
PMID:25193878
NCBI chr 5:62,276,100...62,621,737
Ensembl chr 5:62,276,100...62,621,737
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
affects expression
ISO
quercitrin affects the expression of GADD45 mRNA
CTD
PMID:25193878
NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
G
Galk2
galactokinase 2
increases expression
ISO
quercitrin results in increased expression of GALK2 mRNA
CTD
PMID:25193878
NCBI chr 3:118,137,097...118,268,838
Ensembl chr 3:118,136,838...118,268,836
G
Galr3
galanin receptor 3
increases expression
ISO
quercitrin results in increased expression of GALR3 mRNA
CTD
PMID:25193878
NCBI chr 7:120,271,451...120,276,243
Ensembl chr 7:120,273,117...120,275,581
G
Gimap6
GTPase, IMAP family member 6
increases expression
ISO
quercitrin results in increased expression of GIMAP6 mRNA
CTD
PMID:25193878
NCBI chr 4:78,337,528...78,342,937
Ensembl chr 4:78,336,423...78,342,863
G
Glipr1
GLI pathogenesis-related 1
decreases expression
ISO
quercitrin results in decreased expression of GLIPR1 mRNA
CTD
PMID:25193878
NCBI chr 7:54,767,828...54,778,823
Ensembl chr 7:54,767,827...54,778,848
G
Golim4
golgi integral membrane protein 4
increases expression
ISO
quercitrin results in increased expression of GOLIM4 mRNA
CTD
PMID:25193878
NCBI chr 2:174,321,303...174,413,847
Ensembl chr 2:174,322,673...174,413,236
G
Gpr137b
G protein-coupled receptor 137B
increases expression
ISO
quercitrin results in increased expression of GPR137B mRNA
CTD
PMID:25193878
NCBI chr17:90,670,852...90,709,003
Ensembl chr17:90,670,872...90,746,804
G
Gpr173
G-protein coupled receptor 173
increases expression
ISO
quercitrin results in increased expression of GPR173 mRNA
CTD
PMID:25193878
NCBI chr X:22,417,753...22,418,873
Ensembl chr X:22,417,753...22,418,873
G
Gpr174
G protein-coupled receptor 174
increases expression
ISO
quercitrin results in increased expression of GPR174 mRNA
CTD
PMID:25193878
NCBI chr X:78,358,347...78,399,944
Ensembl chr X:78,372,257...78,399,944
G
Gpr19
G protein-coupled receptor 19
increases expression
ISO
quercitrin results in increased expression of GPR19 mRNA
CTD
PMID:25193878
NCBI chr 4:168,639,930...168,668,345
Ensembl chr 4:168,639,940...168,656,673
G
Gpr4
G protein-coupled receptor 4
increases expression
ISO
quercitrin results in increased expression of GPR4 mRNA
CTD
PMID:25193878
NCBI chr 1:80,125,639...80,136,786
Ensembl chr 1:80,135,391...80,136,880
G
Gpr63
G protein-coupled receptor 63
increases expression
ISO
quercitrin results in increased expression of GPR63 mRNA
CTD
PMID:25193878
NCBI chr 5:39,258,438...39,374,187
Ensembl chr 5:39,329,423...39,370,900
G
Gpr83
G protein-coupled receptor 83
increases expression
ISO
quercitrin results in increased expression of GPR83 mRNA
CTD
PMID:25193878
NCBI chr 8:13,365,583...13,376,071
Ensembl chr 8:13,365,583...13,376,070
G
Gstp1
glutathione S-transferase pi 1
decreases expression
ISO
quercitrin results in decreased expression of GSTP1 mRNA
CTD
PMID:25193878
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
G
Havcr2
hepatitis A virus cellular receptor 2
increases expression
ISO
quercitrin results in increased expression of HAVCR2 mRNA
CTD
PMID:25193878
NCBI chr10:31,561,838...31,590,624
Ensembl chr10:31,561,895...31,588,943
G
Hgf
hepatocyte growth factor
increases expression
ISO
quercitrin results in increased expression of HGF mRNA
CTD
PMID:25193878
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
G
Hmga2
high mobility group AT-hook 2
increases expression
ISO
quercitrin results in increased expression of HMGA2 mRNA
CTD
PMID:25193878
NCBI chr 7:65,159,944...65,275,408
Ensembl chr 7:65,159,944...65,275,408
G
Hmgb2
high mobility group box 2
decreases expression
ISO
quercitrin results in decreased expression of HMGB2 mRNA
CTD
PMID:25193878
NCBI chr16:36,077,615...36,080,191
Ensembl chr16:36,077,617...36,080,191 Ensembl chr11:36,077,617...36,080,191
G
Hnf4a
hepatocyte nuclear factor 4, alpha
decreases expression
ISO
quercitrin results in decreased expression of HNF4A mRNA
CTD
PMID:25193878
NCBI chr 3:159,902,441...159,965,003
Ensembl chr 3:159,902,441...159,965,003
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
affects expression
ISO
quercitrin affects the expression of HSP90AA1 mRNA
CTD
PMID:25193878
NCBI chr 6:135,107,262...135,112,793
Ensembl chr 6:135,107,271...135,112,775
G
Hspa1l
heat shock protein family A (Hsp70) member 1 like
affects expression
ISO
quercitrin affects the expression of HSPA1L mRNA
CTD
PMID:25193878
NCBI chr20:4,879,998...4,965,191
Ensembl chr20:4,959,294...4,964,963
G
Hspa8
heat shock protein family A (Hsp70) member 8
affects expression
ISO
quercitrin affects the expression of HSPA8 mRNA
CTD
PMID:25193878
NCBI chr 8:44,989,401...44,993,261
Ensembl chr 8:44,990,014...44,993,179
G
Ifng
interferon gamma
multiple interactions
EXP
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of BAX protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of RELA protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in decreased expression of NFKBIA protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased cleavage of PARP1 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of CASP3 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]
CTD
PMID:23138875
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
G
Igf1r
insulin-like growth factor 1 receptor
affects expression
ISO
quercitrin affects the expression of IGF1R mRNA
CTD
PMID:25193878
NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516
G
Il15
interleukin 15
decreases expression
ISO
quercitrin results in decreased expression of IL15 mRNA
CTD
PMID:25193878
NCBI chr19:23,542,606...23,624,366
Ensembl chr19:23,542,889...23,554,594
G
Il1b
interleukin 1 beta
multiple interactions
EXP
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of BAX protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of RELA protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in decreased expression of NFKBIA protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased cleavage of PARP1 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of CASP3 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]
CTD
PMID:23138875
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Ino80c
INO80 complex subunit C
decreases expression
ISO
quercitrin results in decreased expression of INO80C mRNA
CTD
PMID:25193878
NCBI chr18:15,995,005...16,009,639
Ensembl chr18:15,995,000...16,009,710
G
Inpp4a
inositol polyphosphate-4-phosphatase type I A
affects expression
ISO
quercitrin affects the expression of INPP4A mRNA
CTD
PMID:25193878
NCBI chr 9:43,889,887...44,006,593
Ensembl chr 9:43,889,473...44,004,325
G
Inpp5d
inositol polyphosphate-5-phosphatase D
affects expression
ISO
quercitrin affects the expression of INPP5D mRNA
CTD
PMID:25193878
NCBI chr 9:94,745,220...94,850,778
Ensembl chr 9:94,745,217...94,850,771
G
Insr
insulin receptor
affects expression
ISO
quercitrin affects the expression of INSR mRNA
CTD
PMID:25193878
NCBI chr12:1,682,527...1,816,414
Ensembl chr12:1,680,957...1,816,414
G
Irf2bp2
interferon regulatory factor 2 binding protein 2
increases expression
ISO
quercitrin results in increased expression of IRF2BP2 mRNA
CTD
PMID:25193878
NCBI chr19:59,497,021...59,502,298
Ensembl chr19:59,499,876...59,502,161
G
Itgb1
integrin subunit beta 1
affects expression
ISO
quercitrin affects the expression of ITGB1 mRNA
CTD
PMID:25193878
NCBI chr19:61,677,512...61,725,537
Ensembl chr19:61,677,542...61,725,535
G
Jaml
junction adhesion molecule like
increases expression
ISO
quercitrin results in increased expression of JAML mRNA
CTD
PMID:25193878
NCBI chr 8:49,378,644...49,408,894
Ensembl chr 8:49,378,644...49,410,088
G
Jpt2
Jupiter microtubule associated homolog 2
increases expression
ISO
quercitrin results in increased expression of JPT2 mRNA
CTD
PMID:25193878
NCBI chr10:14,304,108...14,324,170
Ensembl chr10:14,304,104...14,324,211
G
Kat5
lysine acetyltransferase 5
affects expression
ISO
quercitrin affects the expression of TIP60 mRNA
CTD
PMID:25193878
NCBI chr 1:220,967,795...220,974,596
Ensembl chr 1:220,967,796...220,974,597
G
Kdm3a
lysine demethylase 3A
increases expression
ISO
quercitrin results in increased expression of KDM3A mRNA
CTD
PMID:25193878
NCBI chr 4:99,503,160...99,547,315
Ensembl chr 4:99,503,176...99,546,905
G
Kdr
kinase insert domain receptor
increases expression
ISO
quercitrin results in increased expression of KDR mRNA
CTD
PMID:25193878
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
G
Keap1
Kelch-like ECH-associated protein 1
increases expression
ISO
quercitrin results in increased expression of KEAP1 mRNA
CTD
PMID:25193878
NCBI chr 8:22,250,518...22,259,868
Ensembl chr 8:22,250,518...22,259,779
G
Klhl28
kelch-like family member 28
increases expression
ISO
quercitrin results in increased expression of KLHL28 mRNA
CTD
PMID:25193878
NCBI chr 6:86,680,826...86,713,370
Ensembl chr 6:86,684,413...86,713,370
G
Krt81
keratin 81
decreases expression
ISO
quercitrin results in decreased expression of KRT81 mRNA
CTD
PMID:25193878
NCBI chr 7:143,107,901...143,113,006
Ensembl chr 7:143,107,901...143,112,960
G
Lef1
lymphoid enhancer binding factor 1
affects expression
ISO
quercitrin affects the expression of LEF1 mRNA
CTD
PMID:25193878
NCBI chr 2:236,232,115...236,345,061
Ensembl chr 2:236,233,239...236,345,056
G
LOC100364500
RT1 class I, locus CE11-like
affects expression
ISO
quercitrin affects the expression of HLA-A mRNA
CTD
PMID:25193878
NCBI chr20:2,704,153...2,707,111
Ensembl chr20:2,704,148...2,707,120
G
LOC100911237
zinc finger protein 420-like
increases expression
ISO
quercitrin results in increased expression of ZNF502 mRNA
CTD
PMID:25193878
NCBI chr 1:31,494,043...31,519,034
G
LOC102552569
P2Y purinoceptor 11-like
increases expression
ISO
quercitrin results in increased expression of P2RY11 mRNA
CTD
PMID:25193878
NCBI chr 8:21,910,636...21,911,499
G
LOC686035
similar to heat shock 70kDa protein 6 (HSP70B)
affects expression
ISO
quercitrin affects the expression of HSPA6 mRNA
CTD
PMID:25193878
NCBI chr13:89,408,703...89,411,500
G
Lpar3
lysophosphatidic acid receptor 3
increases expression
ISO
quercitrin results in increased expression of LPAR3 mRNA
CTD
PMID:25193878
NCBI chr 2:252,090,634...252,159,221
Ensembl chr 2:252,090,669...252,159,903
G
Lpar5
lysophosphatidic acid receptor 5
increases expression
ISO
quercitrin results in increased expression of LPAR5 mRNA
CTD
PMID:25193878
NCBI chr 4:157,581,000...157,596,454
Ensembl chr 4:157,594,436...157,595,972
G
Lpar6
lysophosphatidic acid receptor 6
decreases expression
ISO
quercitrin results in decreased expression of LPAR6 mRNA
CTD
PMID:25193878
NCBI chr15:55,126,953...55,128,762
Ensembl chr15:55,126,953...55,128,761
G
Mat2a
methionine adenosyltransferase 2A
increases expression
ISO
quercitrin results in increased expression of MAT2A mRNA
CTD
PMID:25193878
NCBI chr 4:100,297,478...100,303,047
Ensembl chr 4:100,296,075...100,303,080
G
Mc1r
melanocortin 1 receptor
increases expression
ISO
quercitrin results in increased expression of MC1R mRNA
CTD
PMID:25193878
NCBI chr19:56,215,420...56,219,987
G
Mcts1
MCTS1, re-initiation and release factor
decreases expression
ISO
quercitrin results in decreased expression of MCTS1 mRNA
CTD
PMID:25193878
NCBI chr X:124,894,269...124,906,129
Ensembl chr X:124,894,466...124,906,162
G
Mrpl12
mitochondrial ribosomal protein L12
decreases expression
ISO
quercitrin results in decreased expression of MRPL12 mRNA
CTD
PMID:25193878
NCBI chr10:109,658,032...109,662,535
Ensembl chr10:109,658,032...109,662,535
G
Mrpl22
mitochondrial ribosomal protein L22
decreases expression
ISO
quercitrin results in decreased expression of MRPL22 mRNA
CTD
PMID:25193878
NCBI chr10:43,601,786...43,612,119
Ensembl chr10:43,601,689...43,612,121
G
Msn
moesin
affects expression
ISO
quercitrin affects the expression of MSN mRNA
CTD
PMID:25193878
NCBI chr X:65,226,834...65,294,192
Ensembl chr X:65,226,748...65,295,810
G
Myl2
myosin light chain 2
affects expression
ISO
quercitrin affects the expression of MYL2 mRNA
CTD
PMID:25193878
NCBI chr12:39,951,863...39,959,065
Ensembl chr12:39,951,987...39,958,239
G
Myl9
myosin light chain 9
affects expression
ISO
quercitrin affects the expression of MYL9 mRNA
CTD
PMID:25193878
NCBI chr 3:152,857,573...152,863,961
Ensembl chr 3:152,857,592...152,863,960
G
Myom2
myomesin 2
increases expression
ISO
quercitrin results in increased expression of MYOM2 mRNA
CTD
PMID:25193878
NCBI chr16:79,587,136...79,672,871
Ensembl chr16:79,587,640...79,671,719
G
Naa38
N(alpha)-acetyltransferase 38, NatC auxiliary subunit
decreases expression
ISO
quercitrin results in decreased expression of LSMD1 mRNA
CTD
PMID:25193878
NCBI chr10:55,997,614...55,998,691
Ensembl chr10:55,997,614...55,998,691
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
EXP
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in decreased expression of NFKBIA protein]
CTD
PMID:23138875
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
G
Nfrkb
nuclear factor related to kappa B binding protein
increases expression
ISO
quercitrin results in increased expression of NFRKB mRNA
CTD
PMID:25193878
NCBI chr 8:32,530,412...32,561,955
Ensembl chr 8:32,530,412...32,561,955
G
Nmur1
neuromedin U receptor 1
decreases expression
ISO
quercitrin results in decreased expression of NMUR1 mRNA
CTD
PMID:25193878
NCBI chr 9:93,402,871...93,407,264
Ensembl chr 9:93,403,314...93,404,883
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]
CTD
PMID:23138875
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
G
Npbwr1
neuropeptides B and W receptor 1
increases expression
ISO
quercitrin results in increased expression of NPBWR1 mRNA
CTD
PMID:25193878
NCBI chr 5:13,379,772...13,380,761
Ensembl chr 5:13,379,772...13,380,761
G
Npffr2
neuropeptide FF receptor 2
decreases expression
ISO
quercitrin results in decreased expression of NPFFR2 mRNA
CTD
PMID:25193878
NCBI chr14:20,148,485...20,193,577
Ensembl chr14:20,148,913...20,193,083
G
Npy5r
neuropeptide Y receptor Y5
increases expression
ISO
quercitrin results in increased expression of NPY5R mRNA
CTD
PMID:25193878
NCBI chr16:24,796,685...24,805,730
Ensembl chr16:24,797,124...24,805,079
G
Nuak2
NUAK family kinase 2
decreases expression
ISO
quercitrin results in decreased expression of NUAK2 mRNA
CTD
PMID:25193878
NCBI chr13:49,092,306...49,109,055
Ensembl chr13:49,092,306...49,109,050
G
Ocln
occludin
affects expression
ISO
quercitrin affects the expression of OCLN mRNA
CTD
PMID:25193878
NCBI chr 2:30,527,327...30,577,218
Ensembl chr 2:30,527,715...30,577,218
G
Odc1
ornithine decarboxylase 1
increases expression
ISO
quercitrin results in increased expression of ODC1 mRNA
CTD
PMID:25193878
NCBI chr 6:42,852,529...42,859,142
Ensembl chr 6:42,852,683...42,859,927
G
Oga
O-GlcNAcase
increases expression
ISO
quercitrin results in increased expression of OGA mRNA
CTD
PMID:25193878
NCBI chr 1:265,506,752...265,542,452
Ensembl chr 1:265,507,451...265,542,276
G
Ogfod2
2-oxoglutarate and iron-dependent oxygenase domain containing 2
increases expression
ISO
quercitrin results in increased expression of OGFOD2 mRNA
CTD
PMID:25193878
NCBI chr12:37,907,130...37,910,446
Ensembl chr12:37,907,130...37,910,439
G
Oma1
OMA1 zinc metallopeptidase
increases expression
ISO
quercitrin results in increased expression of OMA1 mRNA
CTD
PMID:25193878
NCBI chr 5:122,847,624...122,900,475
Ensembl chr 5:122,847,645...122,900,475
G
P2rx2
purinergic receptor P2X 2
increases expression
ISO
quercitrin results in increased expression of P2RX2 mRNA
CTD
PMID:25193878
NCBI chr12:52,397,666...52,401,005
Ensembl chr12:52,397,792...52,401,015
G
P2rx3
purinergic receptor P2X 3
increases expression
ISO
quercitrin results in increased expression of P2RX3 mRNA
CTD
PMID:25193878
NCBI chr 3:72,403,992...72,447,801
Ensembl chr 3:72,403,993...72,447,801
G
P2ry6
pyrimidinergic receptor P2Y6
decreases expression
ISO
quercitrin results in decreased expression of P2RY6 mRNA
CTD
PMID:25193878
NCBI chr 1:165,972,439...166,008,348
Ensembl chr 1:165,972,440...165,997,751
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
EXP
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased cleavage of PARP1 protein]
CTD
PMID:23138875
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
G
Patz1
POZ (BTB) and AT hook containing zinc finger 1
decreases expression
ISO
quercitrin results in decreased expression of PATZ1 mRNA
CTD
PMID:25193878
NCBI chr14:83,509,763...83,528,898
Ensembl chr14:83,510,278...83,528,898
G
Pex16
peroxisomal biogenesis factor 16
decreases expression
ISO
quercitrin results in decreased expression of PEX16 mRNA
CTD
PMID:25193878
NCBI chr 3:81,283,137...81,292,575
Ensembl chr 3:81,283,137...81,292,573
G
Pidd1
p53-induced death domain protein 1
increases expression
ISO
quercitrin results in increased expression of PIDD1 mRNA
CTD
PMID:25193878
NCBI chr 1:214,418,751...214,423,959
Ensembl chr 1:214,419,240...214,423,881
G
Pik3c2a
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
affects expression
ISO
quercitrin affects the expression of PIK3C2A mRNA
CTD
PMID:25193878
NCBI chr 1:185,210,922...185,326,314
Ensembl chr 1:185,210,922...185,326,314
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
affects expression
ISO
quercitrin affects the expression of PIK3R1 mRNA
CTD
PMID:25193878
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
G
Plcb2
phospholipase C, beta 2
affects expression
ISO
quercitrin affects the expression of PLCB2 mRNA
CTD
PMID:25193878
NCBI chr 3:110,497,760...110,517,563
Ensembl chr 3:110,498,114...110,517,163
G
Plce1
phospholipase C, epsilon 1
affects expression
ISO
quercitrin affects the expression of PLCE1 mRNA
CTD
PMID:25193878
NCBI chr 1:257,156,023...257,465,440
Ensembl chr 1:257,157,264...257,466,064
G
Plgrkt
plasminogen receptor with a C-terminal lysine
decreases expression
ISO
quercitrin results in decreased expression of PLGRKT mRNA
CTD
PMID:25193878
NCBI chr 1:247,502,274...247,514,540
Ensembl chr 1:247,502,280...247,514,540
G
Poc1a
POC1 centriolar protein A
decreases expression
ISO
quercitrin results in decreased expression of POC1A mRNA
CTD
PMID:25193878
NCBI chr 8:114,982,764...115,050,844
Ensembl chr 8:114,986,326...115,050,728
G
Polh
DNA polymerase eta
increases expression
ISO
quercitrin results in increased expression of POLH mRNA
CTD
PMID:25193878
NCBI chr 9:17,163,354...17,198,006
Ensembl chr 9:17,163,354...17,197,132
G
Polrmt
RNA polymerase mitochondrial
decreases expression
ISO
quercitrin results in decreased expression of POLRMT mRNA
CTD
PMID:25193878
NCBI chr 7:12,840,907...12,851,153
Ensembl chr 7:12,840,938...12,851,153
G
Pomt2
protein-O-mannosyltransferase 2
increases expression
ISO
quercitrin results in increased expression of POMT2 mRNA
CTD
PMID:25193878
NCBI chr 6:111,137,329...111,176,991
Ensembl chr 6:111,135,349...111,176,918
G
Pou5f2
POU domain class 5, transcription factor 2
decreases expression
ISO
quercitrin results in decreased expression of POU5F2 mRNA
CTD
PMID:25193878
NCBI chr 2:5,437,067...5,438,301
Ensembl chr 2:5,437,067...5,438,301
G
Prkcb
protein kinase C, beta
affects expression
ISO
quercitrin affects the expression of PRKCB mRNA
CTD
PMID:25193878
NCBI chr 1:192,233,569...192,575,339
Ensembl chr 1:192,233,910...192,574,831
G
Prr3
proline rich 3
decreases expression
ISO
quercitrin results in decreased expression of PRR3 mRNA
CTD
PMID:25193878
NCBI chr20:3,300,247...3,307,262
Ensembl chr20:3,299,730...3,307,673
G
Psd4
pleckstrin and Sec7 domain containing 4
increases expression
ISO
quercitrin results in increased expression of PSD4 mRNA
CTD
PMID:25193878
NCBI chr 3:1,478,432...1,515,094
Ensembl chr 3:1,478,525...1,514,934
G
Psma6
proteasome 20S subunit alpha 6
decreases expression
ISO
quercitrin results in decreased expression of PSMA6 mRNA
CTD
PMID:25193878
NCBI chr 6:76,174,460...76,205,429
Ensembl chr 6:76,174,452...76,205,426
G
Psma8
proteasome 20S subunit alpha 8
decreases expression
ISO
quercitrin results in decreased expression of PSMA8 mRNA
CTD
PMID:25193878
NCBI chr18:6,114,757...6,182,393
Ensembl chr18:6,114,701...6,182,535
G
Psmb6
proteasome 20S subunit beta 6
decreases expression
ISO
quercitrin results in decreased expression of PSMB6 mRNA
CTD
PMID:25193878
NCBI chr10:57,131,339...57,133,685
Ensembl chr10:57,131,386...57,133,637
G
Psmb9
proteasome 20S subunit beta 9
decreases expression
ISO
quercitrin results in decreased expression of PSMB9 mRNA
CTD
PMID:25193878
NCBI chr20:3,973,424...3,978,845
Ensembl chr20:3,973,420...3,978,845
G
Ptgdr2
prostaglandin D2 receptor 2
increases expression
ISO
quercitrin results in increased expression of PTGDR2 mRNA
CTD
PMID:25193878
NCBI chr 1:226,976,455...226,995,641
Ensembl chr 1:226,993,250...226,994,849
G
Ptk2b
protein tyrosine kinase 2 beta
affects expression
ISO
quercitrin affects the expression of PTK2B mRNA
CTD
PMID:25193878
NCBI chr15:42,827,306...42,947,796
Ensembl chr15:42,827,310...42,947,656
G
Ptpru
protein tyrosine phosphatase, receptor type, U
decreases expression
ISO
quercitrin results in decreased expression of PTPRU mRNA
CTD
PMID:25193878
NCBI chr 5:149,922,374...149,996,352
Ensembl chr 5:149,922,352...149,996,334
G
Rac3
Rac family small GTPase 3
affects expression
ISO
quercitrin affects the expression of RAC3 mRNA
CTD
PMID:25193878
NCBI chr10:109,903,920...109,906,596
Ensembl chr10:109,904,259...109,906,232
G
Rap1a
RAP1A, member of RAS oncogene family
affects expression
ISO
quercitrin affects the expression of RAP1A mRNA
CTD
PMID:25193878
NCBI chr 2:208,193,950...208,215,186
Ensembl chr 2:208,193,954...208,215,187
G
Rbak
RB-associated KRAB zinc finger
increases expression
ISO
quercitrin results in increased expression of RBAK mRNA
CTD
PMID:25193878
NCBI chr12:13,428,648...13,442,279
Ensembl chr12:13,428,685...13,442,286
G
Rbks
ribokinase
decreases expression
ISO
quercitrin results in decreased expression of RBKS mRNA
CTD
PMID:25193878
NCBI chr 6:26,051,568...26,128,762
Ensembl chr 6:26,051,396...26,128,906
G
Rbm15b
RNA binding motif protein 15B
increases expression
ISO
quercitrin results in increased expression of RBM15B mRNA
CTD
PMID:25193878
NCBI chr 8:115,618,242...115,623,068
Ensembl chr 8:115,618,555...115,621,394
G
Rbm38
RNA binding motif protein 38
increases expression
ISO
quercitrin results in increased expression of RBM38 mRNA
CTD
PMID:25193878
NCBI chr 3:171,037,891...171,050,500
Ensembl chr 3:171,037,957...171,050,475
G
Rbm39
RNA binding motif protein 39
increases expression
ISO
quercitrin results in increased expression of RBM39 mRNA
CTD
PMID:25193878
NCBI chr 3:151,691,498...151,724,723
Ensembl chr 3:151,691,514...151,724,654
G
Rchy1
ring finger and CHY zinc finger domain containing 1
decreases expression
ISO
quercitrin results in decreased expression of RCHY1 mRNA
CTD
PMID:25193878
NCBI chr14:17,615,968...17,631,715
Ensembl chr14:17,615,968...17,631,714
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of RELA protein]
CTD
PMID:23138875
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
G
RGD1310553
similar to expressed sequence AI597479
decreases expression
ISO
quercitrin results in decreased expression of C2ORF49 mRNA
CTD
PMID:25193878
NCBI chr 9:49,903,085...49,913,754
Ensembl chr 9:49,903,085...49,913,744
G
Riok1
RIO kinase 1
increases expression
ISO
quercitrin results in increased expression of RIOK1 mRNA
CTD
PMID:25193878
NCBI chr17:27,429,421...27,452,353
Ensembl chr17:27,429,416...27,452,314
G
Rnf14
ring finger protein 14
decreases expression
ISO
quercitrin results in decreased expression of RNF14 mRNA
CTD
PMID:25193878
NCBI chr18:31,443,424...31,468,641
Ensembl chr18:31,444,472...31,468,640
G
Rock1
Rho-associated coiled-coil containing protein kinase 1
affects expression
ISO
quercitrin affects the expression of ROCK1 mRNA
CTD
PMID:25193878
NCBI chr18:1,273,490...1,390,790
Ensembl chr18:1,273,453...1,390,190
G
RT1-Ba
RT1 class II, locus Ba
affects expression
ISO
quercitrin affects the expression of HLA-DQA1 mRNA
CTD
PMID:25193878
NCBI chr20:4,066,133...4,070,726
Ensembl chr20:4,066,132...4,070,721
G
RT1-S3
RT1 class Ib, locus S3
affects expression
ISO
quercitrin affects the expression of HLA-E mRNA
CTD
PMID:25193878
NCBI chr20:3,176,124...3,180,825
Ensembl chr20:3,176,107...3,179,818
G
Sap18
Sin3A associated protein 18
increases expression
ISO
quercitrin results in increased expression of SAP18 mRNA
CTD
PMID:25193878
NCBI chr15:38,069,320...38,073,625
Ensembl chr15:38,069,320...38,073,622
G
Sat1
spermidine/spermine N1-acetyl transferase 1
decreases expression
ISO
quercitrin results in decreased expression of SAT1 mRNA
CTD
PMID:25193878
NCBI chr X:43,626,480...43,629,767
Ensembl chr X:43,625,169...43,629,765
G
Sertad1
SERTA domain containing 1
increases expression
ISO
quercitrin results in increased expression of SERTAD1 mRNA
CTD
PMID:25193878
NCBI chr 1:84,293,102...84,296,370
Ensembl chr 1:84,293,102...84,296,367
G
Sf3b1
splicing factor 3b, subunit 1
decreases expression
ISO
quercitrin results in decreased expression of SF3B1 mRNA
CTD
PMID:25193878
NCBI chr 9:61,594,620...61,634,510
Ensembl chr 9:61,594,620...61,634,510
G
Slc16a13
solute carrier family 16, member 13
decreases expression
ISO
quercitrin results in decreased expression of SLC16A13 mRNA
CTD
PMID:25193878
NCBI chr10:56,827,591...56,831,324
Ensembl chr10:56,827,594...56,831,243
G
Slc16a4
solute carrier family 16, member 4
decreases expression
ISO
quercitrin results in decreased expression of SLC16A4 mRNA
CTD
PMID:25193878
NCBI chr 2:210,045,122...210,161,017
Ensembl chr 2:210,045,161...210,068,502
G
Slc22a18
solute carrier family 22, member 18
decreases expression
ISO
quercitrin results in decreased expression of SLC22A18 mRNA
CTD
PMID:25193878
NCBI chr 1:216,676,330...216,700,632
Ensembl chr 1:216,677,373...216,700,641
G
Slc25a40
solute carrier family 25, member 40
decreases expression
ISO
quercitrin results in decreased expression of SLC25A40 mRNA
CTD
PMID:25193878
NCBI chr 4:22,619,700...22,661,685
Ensembl chr 4:22,576,576...22,661,722
G
Slc39a8
solute carrier family 39 member 8
decreases expression
ISO
quercitrin results in decreased expression of SLC39A8 mRNA
CTD
PMID:25193878
NCBI chr 2:241,028,851...241,092,584
Ensembl chr 2:241,029,693...241,092,582
G
Slc7a9
solute carrier family 7 member 9
increases expression
ISO
quercitrin results in increased expression of SLC7A9 mRNA
CTD
PMID:25193878
NCBI chr 1:91,709,034...91,738,492
Ensembl chr 1:91,716,383...91,738,494
G
Slfnl1
schlafen-like 1
increases expression
ISO
quercitrin results in increased expression of SLFNL1 mRNA
CTD
PMID:25193878
NCBI chr 5:139,467,933...139,473,599
Ensembl chr 5:139,468,546...139,473,017
G
Smad3
SMAD family member 3
increases expression
ISO
quercitrin results in increased expression of SMAD3 mRNA
CTD
PMID:25193878
NCBI chr 8:68,569,530...68,678,349
Ensembl chr 8:68,569,530...68,678,349
G
Smpd1
sphingomyelin phosphodiesterase 1
increases expression
ISO
quercitrin results in increased expression of SMPD1 mRNA
CTD
PMID:25193878
NCBI chr 1:170,383,682...170,387,525
Ensembl chr 1:170,383,682...170,387,524
G
Snai2
snail family transcriptional repressor 2
affects expression
ISO
quercitrin affects the expression of SNAI2 mRNA
CTD
PMID:25193878
NCBI chr11:90,404,421...90,406,730
Ensembl chr11:90,403,333...90,406,797
G
Sorbs1
sorbin and SH3 domain containing 1
affects expression
ISO
quercitrin affects the expression of SORBS1 mRNA
CTD
PMID:25193878
NCBI chr 1:259,373,921...259,502,108
Ensembl chr 1:259,376,933...259,484,569
G
Sorl1
sortilin related receptor 1
decreases expression
ISO
quercitrin results in decreased expression of SORL1 mRNA
CTD
PMID:25193878
NCBI chr 8:46,228,077...46,287,171
G
Sp4
Sp4 transcription factor
increases expression
ISO
quercitrin results in increased expression of SP4 mRNA
CTD
PMID:25193878
NCBI chr 6:146,135,877...146,201,344
Ensembl chr 6:146,135,877...146,195,819
G
Spata18
spermatogenesis associated 18
increases expression
ISO
quercitrin results in increased expression of SPATA18 mRNA
CTD
PMID:25193878
NCBI chr14:37,081,529...37,108,245
Ensembl chr14:37,081,427...37,108,341
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
affects expression
ISO
quercitrin affects the expression of SRC mRNA
CTD
PMID:25193878
NCBI chr 3:153,547,807...153,595,643
Ensembl chr 3:153,580,861...153,595,642
G
Srd5a3
steroid 5 alpha-reductase 3
increases expression
ISO
quercitrin results in increased expression of SRD5A3 mRNA
CTD
PMID:25193878
NCBI chr14:34,554,769...34,570,423
Ensembl chr14:34,556,220...34,570,356
G
Srrm2
serine/arginine repetitive matrix 2
increases expression
ISO
quercitrin results in increased expression of SRRM2 mRNA
CTD
PMID:25193878
NCBI chr10:13,128,820...13,162,956
Ensembl chr10:13,145,099...13,162,343
G
Sugct
succinylCoA:glutarate-CoA transferase
increases expression
ISO
quercitrin results in increased expression of SUGCT mRNA
CTD
PMID:25193878
NCBI chr17:49,991,314...51,030,950
G
Sugp1
SURP and G patch domain containing 1
increases expression
ISO
quercitrin results in increased expression of SUGP1 mRNA
CTD
PMID:25193878
NCBI chr16:21,100,923...21,131,795
Ensembl chr16:21,100,924...21,131,795
G
Tcea1
transcription elongation factor A1
decreases expression
ISO
quercitrin results in decreased expression of TCEA1 mRNA
CTD
PMID:25193878
NCBI chr 5:14,511,183...14,548,494
Ensembl chr 5:14,511,183...14,548,429
G
Tcea2
transcription elongation factor A2
decreases expression
ISO
quercitrin results in decreased expression of TCEA2 mRNA
CTD
PMID:25193878
NCBI chr 3:177,187,686...177,195,898
Ensembl chr 3:177,188,044...177,195,894
G
Tcf7
transcription factor 7
affects expression
ISO
quercitrin affects the expression of TCF7 mRNA
CTD
PMID:25193878
NCBI chr10:37,616,033...37,646,027
Ensembl chr10:37,617,279...37,645,802
G
Tfb1m
transcription factor B1, mitochondrial
decreases expression
ISO
quercitrin results in decreased expression of TFB1M mRNA
CTD
PMID:25193878
NCBI chr 1:44,433,116...44,474,674
Ensembl chr 1:44,433,116...44,474,674
G
Tgif2
TGFB-induced factor homeobox 2
decreases expression
ISO
quercitrin results in decreased expression of TGIF2 mRNA
CTD
PMID:25193878
NCBI chr 3:152,906,961...152,924,380
Ensembl chr 3:152,909,189...152,924,377
G
Tgm2
transglutaminase 2
decreases expression
ISO
quercitrin results in decreased expression of TGM2 mRNA
CTD
PMID:25193878
NCBI chr 3:154,597,165...154,627,257
Ensembl chr 3:154,597,168...154,627,257
G
Thsd1
thrombospondin type 1 domain containing 1
increases expression
ISO
quercitrin results in increased expression of THSD1 mRNA
CTD
PMID:25193878
NCBI chr16:74,680,621...74,712,368
Ensembl chr16:74,680,621...74,710,704
G
Tmem160
transmembrane protein 160
decreases expression
ISO
quercitrin results in decreased expression of TMEM160 mRNA
CTD
PMID:25193878
NCBI chr 1:78,417,719...78,420,427
Ensembl chr 1:78,417,719...78,420,427
G
Tmem208
transmembrane protein 208
decreases expression
ISO
quercitrin results in decreased expression of TMEM208 mRNA
CTD
PMID:25193878
NCBI chr19:37,282,018...37,284,718
Ensembl chr19:37,282,018...37,284,718
G
Tmem242
transmembrane protein 242
increases expression
ISO
quercitrin results in increased expression of TMEM242 mRNA
CTD
PMID:25193878
NCBI chr 1:46,302,546...46,329,885
Ensembl chr 1:46,302,970...46,329,682
G
Tmx1
thioredoxin-related transmembrane protein 1
decreases expression
ISO
quercitrin results in decreased expression of TMX1 mRNA
CTD
PMID:25193878
NCBI chr 6:92,864,123...92,875,141
Ensembl chr 6:92,864,123...92,874,204
G
Tnf
tumor necrosis factor
multiple interactions
EXP
quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of BAX protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] affects the localization of RELA protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in decreased expression of NFKBIA protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased cleavage of PARP1 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of CASP3 protein]; quercitrin inhibits the reaction [[TNF protein co-treated with IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]
CTD
PMID:23138875
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tnfrsf1a
TNF receptor superfamily member 1A
decreases expression
ISO
quercitrin results in decreased expression of TNFRSF1A mRNA
CTD
PMID:25193878
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
G
Tnfrsf1b
TNF receptor superfamily member 1B
decreases expression
ISO
quercitrin results in decreased expression of TNFRSF1B mRNA
CTD
PMID:25193878
NCBI chr 5:163,136,390...163,167,299
Ensembl chr 5:163,136,390...163,167,299
G
Tp63
tumor protein p63
decreases expression
ISO
quercitrin results in decreased expression of TP63 mRNA
CTD
PMID:25193878
NCBI chr11:78,234,853...78,456,559
Ensembl chr11:78,234,800...78,456,501
G
Tspan14
tetraspanin 14
decreases expression
ISO
quercitrin results in decreased expression of TSPAN14 mRNA
CTD
PMID:25193878
NCBI chr16:17,538,855...17,595,960
Ensembl chr16:17,538,855...17,595,960
G
U2af2
U2 small nuclear RNA auxiliary factor 2
increases expression
ISO
quercitrin results in increased expression of U2AF2 mRNA
CTD
PMID:25193878
NCBI chr 1:72,312,260...72,329,828
Ensembl chr 1:72,312,727...72,329,856
G
Uts2r
urotensin 2 receptor
increases expression
ISO
quercitrin results in increased expression of UTS2R mRNA
CTD
PMID:25193878
NCBI chr10:110,364,291...110,365,451
Ensembl chr10:110,364,291...110,365,451
G
Vom1r51
vomeronasal 1 receptor 51
increases expression
ISO
quercitrin results in increased expression of VN1R1 mRNA
CTD
PMID:25193878
NCBI chr 1:66,872,787...66,873,740
Ensembl chr 1:66,872,787...66,873,740
G
Vwa8
von Willebrand factor A domain containing 8
decreases expression
ISO
quercitrin results in decreased expression of VWA8 mRNA
CTD
PMID:25193878
NCBI chr15:61,069,439...61,153,292 NCBI chr15:61,158,510...61,467,462
Ensembl chr15:61,069,581...61,152,506
G
Was
WASP actin nucleation promoting factor
affects expression
ISO
quercitrin affects the expression of WAS mRNA
CTD
PMID:25193878
NCBI chr X:15,155,246...15,164,099
Ensembl chr X:15,155,230...15,164,105
G
Wdr33
WD repeat domain 33
decreases expression
ISO
quercitrin results in decreased expression of WDR33 mRNA
CTD
PMID:25193878
NCBI chr18:24,584,832...24,689,681
Ensembl chr18:24,584,900...24,689,636
G
Wwox
WW domain-containing oxidoreductase
decreases expression
ISO
quercitrin results in decreased expression of WWOX mRNA
CTD
PMID:25193878
NCBI chr19:46,761,353...47,695,247
G
Zan
zonadhesin
increases expression
ISO
quercitrin results in increased expression of ZAN mRNA
CTD
PMID:25193878
NCBI chr12:22,285,377...22,389,008
G
Zcchc14
zinc finger CCHC-type containing 14
increases expression
ISO
quercitrin results in increased expression of ZCCHC14 mRNA
CTD
PMID:25193878
NCBI chr19:53,644,500...53,688,624
Ensembl chr19:53,647,815...53,688,597
G
Abca1
ATP binding cassette subfamily A member 1
multiple interactions
EXP
Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABCA1 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABCA1 protein]
CTD
PMID:25478064
NCBI chr 5:69,857,717...69,983,042
Ensembl chr 5:69,857,771...69,983,015
G
Acly
ATP citrate lyase
decreases activity
ISO
Rutin results in decreased activity of ACLY protein
CTD
PMID:17032037
NCBI chr10:88,392,248...88,442,845
Ensembl chr10:88,392,248...88,442,845
G
Ager
advanced glycosylation end product-specific receptor
multiple interactions
ISO
Rutin inhibits the reaction [Glucose results in increased expression of AGER mRNA]
CTD
PMID:19557821
NCBI chr20:4,363,152...4,366,079
Ensembl chr20:4,363,152...4,366,079
G
Agt
angiotensinogen
multiple interactions
EXP
Rutin inhibits the reaction [Isoproterenol results in increased expression of AGT protein]
CTD
PMID:24117263
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
G
Ahr
aryl hydrocarbon receptor
decreases localization multiple interactions
ISO
Rutin results in decreased localization of AHR protein Rutin promotes the reaction [6-formylindolo(3,2-b)carbazole results in increased localization of AHR protein]
CTD
PMID:21756928
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in decreased phosphorylation of AKT1 protein]
CTD
PMID:22426011
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
G
Arnt
aryl hydrocarbon receptor nuclear translocator
increases localization
ISO
Rutin results in increased localization of ARNT protein
CTD
PMID:21756928
NCBI chr 2:196,594,178...196,651,486
Ensembl chr 2:196,594,303...196,651,179
G
Atxn2
ataxin 2
multiple interactions
EXP
Rutin inhibits the reaction [Oxidopamine results in increased expression of ATXN2 mRNA]
CTD
PMID:25129099
NCBI chr12:40,264,601...40,335,637
Ensembl chr12:40,266,662...40,332,612
G
Atxn3
ataxin 3
multiple interactions
EXP
Rutin inhibits the reaction [Oxidopamine results in increased expression of ATXN3 mRNA]
CTD
PMID:25129099
NCBI chr 6:125,817,420...125,853,461
Ensembl chr 6:125,819,640...125,853,461
G
Bax
BCL2 associated X, apoptosis regulator
affects expression multiple interactions increases expression
ISO
Rutin affects the expression of BAX protein Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of BAX protein] Rutin results in increased expression of BAX protein
CTD
PMID:15975156 PMID:28811126 PMID:29522708
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bbc3
Bcl-2 binding component 3
multiple interactions
EXP
Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of BBC3 mRNA]
CTD
PMID:27239252
NCBI chr 1:78,261,491...78,267,802
G
Bcl2
BCL2, apoptosis regulator
affects expression multiple interactions decreases expression
ISO EXP
Rutin affects the expression of BCL2 protein Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein] Rutin results in decreased expression of BCL2 protein Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 mRNA] Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]
CTD
PMID:15975156 PMID:19557821 PMID:26062544 PMID:28811126 PMID:29522708
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Bcl2l1
Bcl2-like 1
multiple interactions
EXP
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of BCL2L1 mRNA]
CTD
PMID:26062544
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
G
Casp1
caspase 1
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in increased expression of CASP1 protein]
CTD
PMID:22426011
NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631
G
Casp3
caspase 3
affects cleavage increases cleavage multiple interactions increases expression increases activity
ISO EXP
Rutin affects the cleavage of CASP3 protein Rutin results in increased cleavage of CASP3 protein Rutin inhibits the reaction [Cholesterol, Dietary results in increased cleavage of CASP3 protein]; Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of CASP3 mRNA]; Rutin inhibits the reaction [Oxidopamine results in increased expression of CASP3 mRNA] [Rutin binds to Zinc] which results in increased expression of CASP3 mRNA; [Rutin co-treated with Meloxicam] affects the reaction [Formaldehyde affects the expression of CASP3 protein]; Rutin inhibits the reaction [Carbon Tetrachloride results in increased cleavage of CASP3 protein]; Rutin inhibits the reaction [Oxaliplatin results in increased expression of CASP3 protein] Rutin results in increased expression of CASP3 mRNA Rutin results in increased activity of CASP3 protein
CTD
PMID:15975156 PMID:24726691 PMID:24908156 PMID:25129099 PMID:26091902 PMID:27239252 PMID:28811126 PMID:29315975 PMID:29522708
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Casp7
caspase 7
increases activity multiple interactions
ISO EXP
Rutin results in increased activity of CASP7 protein Rutin inhibits the reaction [Oxidopamine results in increased expression of CASP7 mRNA]
CTD
PMID:24726691 PMID:25129099
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
G
Casp8
caspase 8
multiple interactions increases expression
ISO
[Rutin binds to Zinc] which results in increased expression of CASP8 mRNA Rutin results in increased expression of CASP8 mRNA
CTD
PMID:26091902
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
G
Cat
catalase
multiple interactions
ISO EXP
Rutin inhibits the reaction [bifenthrin results in decreased activity of CAT protein] Rutin inhibits the reaction [Lipopolysaccharides results in decreased activity of CAT protein] Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of CAT mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of CAT protein]; Rutin inhibits the reaction [Cisplatin results in decreased expression of CAT protein]; Rutin inhibits the reaction [Cyclophosphamide results in decreased activity of CAT protein]
CTD
PMID:19833193 PMID:21605616 PMID:25478064 PMID:25753322 PMID:29743444
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
G
Cbr1
carbonyl reductase 1
multiple interactions
ISO
Rutin binds to and results in decreased activity of CBR1 protein; Rutin inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]
CTD
PMID:11306090 PMID:18579125
NCBI chr11:33,813,041...33,815,418
Ensembl chr11:33,845,463...33,847,793
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions decreases secretion decreases expression
ISO EXP
Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA] Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 protein] Rutin results in decreased secretion of CCL2 protein Rutin results in decreased expression of CCL2 mRNA
CTD
PMID:21756928 PMID:21967610 PMID:25478064
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions decreases expression
EXP
Lipopolysaccharides inhibits the reaction [Rutin results in decreased expression of CCL5 mRNA]
CTD
PMID:28693884
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
G
Ccn2
cellular communication network factor 2
multiple interactions
EXP
Rutin inhibits the reaction [Isoproterenol results in increased expression of CCN2 mRNA]; Rutin inhibits the reaction [Isoproterenol results in increased expression of CCN2 protein]
CTD
PMID:24117263
NCBI chr 1:21,851,657...21,854,773
Ensembl chr 1:21,851,660...21,854,773
G
Ccnd1
cyclin D1
multiple interactions decreases expression
ISO
[Rutin binds to Zinc] which results in decreased expression of CCND1 mRNA Rutin results in decreased expression of CCND1 mRNA
CTD
PMID:26091902
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
G
Cd68
Cd68 molecule
decreases expression
EXP
Rutin results in decreased expression of CD68 protein
CTD
PMID:28693884
NCBI chr10:56,268,726...56,270,605
Ensembl chr10:56,268,720...56,270,640
G
Csf2
colony stimulating factor 2
multiple interactions
ISO
Rutin inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 mRNA]
CTD
PMID:15652231
NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070
G
Cx3cl1
C-X3-C motif chemokine ligand 1
decreases expression
EXP
Rutin results in decreased expression of CX3CL1 mRNA
CTD
PMID:28693884
NCBI chr19:10,644,267...10,654,861
Ensembl chr19:10,644,244...10,653,800
G
Cxcl10
C-X-C motif chemokine ligand 10
multiple interactions decreases secretion decreases expression
ISO
Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] Rutin results in decreased secretion of CXCL10 protein Rutin results in decreased expression of CXCL10 mRNA
CTD
PMID:21756928 PMID:21967610
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases expression multiple interactions
EXP
Rutin results in decreased expression of CXCL12 mRNA Lipopolysaccharides inhibits the reaction [Rutin results in decreased expression of CXCL12 mRNA]
CTD
PMID:28693884
NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
increases expression
EXP
Rutin results in increased expression of CYP19A1 protein
CTD
PMID:29899696
NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
Rutin results in increased expression of CYP1A1 mRNA
CTD
PMID:21756928
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
Rutin results in decreased activity of CYP1B1 protein
CTD
PMID:16271822
NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
G
Egf
epidermal growth factor
multiple interactions
EXP
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of EGF mRNA]
CTD
PMID:26062544
NCBI chr 2:68,820,616...68,895,537
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
Rutin inhibits the reaction [TGFA protein affects the localization of EGFR protein]
CTD
PMID:21967610
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
G
Egln1
egl-9 family hypoxia-inducible factor 1
multiple interactions
EXP
Rutin inhibits the reaction [Oxidopamine results in increased expression of EGLN1 mRNA]
CTD
PMID:25129099
NCBI chr19:57,660,194...57,701,158
Ensembl chr19:57,662,278...57,699,113
G
Esr2
estrogen receptor 2
increases expression
EXP
Rutin results in increased expression of ESR2 protein
CTD
PMID:29899696
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
G
Fadd
Fas associated via death domain
multiple interactions
EXP
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of FADD mRNA]
CTD
PMID:26062544
NCBI chr 1:217,746,176...217,748,581
Ensembl chr 1:217,742,929...217,748,628
G
Fn1
fibronectin 1
increases expression multiple interactions
ISO EXP
Rutin results in increased expression of FN1 protein Rutin inhibits the reaction [Isoproterenol results in increased expression of FN1 protein]
CTD
PMID:24117263 PMID:26408079
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
Rutin inhibits the reaction [oxaliplatin results in increased expression of FOS protein]
CTD
PMID:24908156
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
Fshr
follicle stimulating hormone receptor
increases expression
EXP
Rutin results in increased expression of FSHR protein
CTD
PMID:29899696
NCBI chr 6:12,796,383...12,997,817
Ensembl chr 6:12,796,383...12,997,817
G
Gdnf
glial cell derived neurotrophic factor
increases expression
EXP
Rutin results in increased expression of GDNF mRNA
CTD
PMID:28693884
NCBI chr 2:56,884,181...56,912,964
Ensembl chr 2:56,887,987...56,910,238
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of GPT protein]; Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of GPT protein]; Rutin inhibits the reaction [Cyclophosphamide results in increased activity of GPT protein]
CTD
PMID:25478064 PMID:25753322 PMID:26062544 PMID:27239252
NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
G
Gpx1
glutathione peroxidase 1
multiple interactions
EXP
Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPX1 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPX1 protein]
CTD
PMID:25478064
NCBI chr 8:117,117,430...117,118,528
Ensembl chr 8:117,117,430...117,118,522
G
Gsr
glutathione-disulfide reductase
decreases activity multiple interactions
ISO EXP
Rutin results in decreased activity of GSR protein Rutin inhibits the reaction [Cisplatin results in decreased expression of GSR protein]; Rutin inhibits the reaction [Cyclophosphamide results in decreased activity of GSR protein]
CTD
PMID:15782287 PMID:21605616 PMID:25753322
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[Rutin co-treated with Carbon Tetrachloride] results in increased expression of HMOX1 protein
CTD
PMID:22902988
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Ifng
interferon gamma
multiple interactions
ISO
Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL8 protein]
CTD
PMID:21756928
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
G
Igf1
insulin-like growth factor 1
multiple interactions
EXP
[Lipopolysaccharides co-treated with Rutin] results in decreased expression of IGF1 mRNA
CTD
PMID:28693884
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
G
Igf1r
insulin-like growth factor 1 receptor
multiple interactions
ISO
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of IGF1R protein]
CTD
PMID:20015448
NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516
G
Il10
interleukin 10
multiple interactions increases expression
EXP
Lipopolysaccharides promotes the reaction [Rutin results in increased expression of IL10 mRNA] Rutin results in increased expression of IL10 mRNA; Rutin results in increased expression of IL10 protein
CTD
PMID:28693884
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Il18
interleukin 18
multiple interactions decreases expression
EXP
Rutin inhibits the reaction [Fructose results in increased expression of IL18 protein] Rutin results in decreased expression of IL18 mRNA
CTD
PMID:22426011 PMID:28693884
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
G
Il1b
interleukin 1 beta
multiple interactions decreases expression
ISO EXP
Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein]; Rutin inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of IL1B protein] Rutin results in decreased expression of IL1B mRNA Lipopolysaccharides inhibits the reaction [Rutin results in decreased expression of IL1B mRNA]; Rutin inhibits the reaction [Fructose results in increased expression of IL1B protein] [Rutin co-treated with Meloxicam] affects the reaction [Formaldehyde affects the expression of IL1B protein]; Rutin affects the reaction [Formaldehyde affects the expression of IL1B protein]; Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of IL1B protein]; Rutin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]
CTD
PMID:15652231 PMID:18958421 PMID:19557821 PMID:22426011 PMID:28693884 PMID:29315975 PMID:29522708
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il6
interleukin 6
multiple interactions decreases expression
ISO EXP
Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA] Rutin results in decreased expression of IL6 mRNA; Rutin results in decreased expression of IL6 protein Lipopolysaccharides inhibits the reaction [Rutin results in decreased expression of IL6 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [Cyclophosphamide results in increased expression of IL6 protein]; Rutin inhibits the reaction [Fructose results in increased expression of IL6 protein] Rutin inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]
CTD
PMID:15652231 PMID:18958421 PMID:21756928 PMID:22426011 PMID:25753322 PMID:26062544 PMID:27239252 PMID:28693884 PMID:29743444
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Insr
insulin receptor
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in decreased phosphorylation of INSR protein]
CTD
PMID:22426011
NCBI chr12:1,682,527...1,816,414
Ensembl chr12:1,680,957...1,816,414
G
Irs1
insulin receptor substrate 1
decreases expression multiple interactions
ISO EXP
Rutin results in decreased expression of IRS1 protein Rutin inhibits the reaction [Fructose results in decreased phosphorylation of IRS1 protein] Rutin results in increased susceptibility to [Vitamin E results in decreased expression of IRS1 protein]; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of IRS1 protein]
CTD
PMID:20015448 PMID:22426011
NCBI chr 9:88,033,668...88,086,488
Ensembl chr 9:88,033,668...88,086,488
G
Itgam
integrin subunit alpha M
increases expression multiple interactions
EXP
Rutin results in increased expression of ITGAM protein Lipopolysaccharides inhibits the reaction [Rutin results in increased expression of ITGAM protein]
CTD
PMID:28693884
NCBI chr 1:199,495,312...199,545,738
Ensembl chr 1:199,495,298...199,623,960
G
Jak1
Janus kinase 1
multiple interactions
EXP
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of JAK1 mRNA]
CTD
PMID:26062544
NCBI chr 5:119,982,503...120,091,452
Ensembl chr 5:119,982,943...120,083,904
G
Jak2
Janus kinase 2
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in decreased phosphorylation of JAK2 protein]
CTD
PMID:22426011
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
decreases expression multiple interactions
ISO
Rutin results in decreased expression of JUN protein Rutin results in increased susceptibility to [Vitamin E results in decreased expression of JUN protein]; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of JUN protein]
CTD
PMID:20015448
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
G
Lamb2
laminin subunit beta 2
increases expression
ISO
Rutin results in increased expression of LAMB2 protein
CTD
PMID:26408079
NCBI chr 8:117,268,335...117,280,517
Ensembl chr 8:117,268,337...117,280,517
G
Lep
leptin
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in increased expression of LEP protein]
CTD
PMID:22426011
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
G
Lepr
leptin receptor
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in increased expression of and results in increased phosphorylation of LEPR protein]
CTD
PMID:22426011
NCBI chr 5:120,503,475...120,682,281
Ensembl chr 5:120,564,645...120,682,221
G
Lgals9
galectin 9
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in decreased expression of LGALS9 mRNA]; Rutin inhibits the reaction [Fructose results in decreased expression of LGALS9 protein]
CTD
PMID:19605544
NCBI chr10:64,737,022...64,760,195
Ensembl chr10:64,737,022...64,760,201
G
Map2k5
mitogen activated protein kinase kinase 5
multiple interactions
EXP
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP2K5 mRNA]
CTD
PMID:26062544
NCBI chr 8:68,055,976...68,282,656
Ensembl chr 8:68,055,972...68,282,590
G
Mapk1
mitogen activated protein kinase 1
multiple interactions decreases phosphorylation
ISO EXP
Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein]; Rutin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] Rutin inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of MAPK1 protein] Rutin inhibits the reaction [Fructose results in decreased phosphorylation of MAPK1 protein] Rutin results in decreased phosphorylation of MAPK1 protein
CTD
PMID:19557821 PMID:21756928 PMID:22426011 PMID:29522708
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
G
Mapk3
mitogen activated protein kinase 3
multiple interactions decreases phosphorylation
ISO EXP
Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein]; Rutin inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein] Rutin inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of MAPK3 protein] Rutin inhibits the reaction [Fructose results in decreased phosphorylation of MAPK3 protein] Rutin results in decreased phosphorylation of MAPK3 protein
CTD
PMID:19557821 PMID:21756928 PMID:22426011 PMID:29522708
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
Rutin results in decreased expression of and results in decreased activity of MMP2 protein Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP2 mRNA]; Rutin inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP2 protein]
CTD
PMID:26408079 PMID:29743444
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mmp9
matrix metallopeptidase 9
decreases expression multiple interactions
ISO
Rutin results in decreased expression of MMP9 mRNA Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]; Rutin inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]
CTD
PMID:16304905 PMID:29743444
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
Mrc1
mannose receptor, C type 1
increases expression multiple interactions
EXP
Rutin results in increased expression of MRC1 protein [Lipopolysaccharides co-treated with Rutin] results in increased expression of MRC1 protein
CTD
PMID:28693884
NCBI chr17:81,352,700...81,433,743
Ensembl chr17:81,352,700...81,433,743
G
Nfe2l2
nuclear factor, erythroid 2-like 2
multiple interactions
ISO EXP
Rutin promotes the reaction [Carbon Tetrachloride results in increased expression of NFE2L2 protein] [Rutin co-treated with Hydrogen Peroxide] affects the localization of NFE2L2 protein
CTD
PMID:22902988 PMID:31412289
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein]
CTD
PMID:19557821
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in increased expression of NLRP3 protein]
CTD
PMID:22426011
NCBI chr10:45,884,324...45,918,290
Ensembl chr10:45,893,018...45,918,254
G
Nos2
nitric oxide synthase 2
multiple interactions decreases expression
EXP ISO
Rutin inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 protein] Rutin results in decreased expression of NOS2 mRNA; Rutin results in decreased expression of NOS2 protein Rutin inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein]; Rutin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:11500931 PMID:12512693 PMID:22902988 PMID:25080890 PMID:25753322 PMID:28693884
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
G
Nsf
N-ethylmaleimide sensitive factor, vesicle fusing ATPase
multiple interactions
EXP
Rutin inhibits the reaction [Oxidopamine results in decreased expression of NSF mRNA]
CTD
PMID:25129099
NCBI chr10:91,879,608...91,986,242
Ensembl chr10:91,878,633...92,008,082
G
Nsg1
neuronal vesicle trafficking associated 1
multiple interactions
EXP
Rutin inhibits the reaction [Oxidopamine results in decreased expression of NSG1 mRNA]
CTD
PMID:25129099
NCBI chr14:77,380,264...77,402,007
Ensembl chr14:77,380,262...77,401,996
G
Opa1
OPA1, mitochondrial dynamin like GTPase
multiple interactions
EXP
Rutin inhibits the reaction [Oxidopamine results in decreased expression of OPA1 mRNA]
CTD
PMID:25129099
NCBI chr11:74,717,600...74,793,902
Ensembl chr11:74,720,254...74,793,803
G
Park7
Parkinsonism associated deglycase
multiple interactions
EXP
Rutin inhibits the reaction [Oxidopamine results in increased expression of PARK7 mRNA]
CTD
PMID:25129099
NCBI chr 5:167,982,438...168,004,724
Ensembl chr 5:167,982,439...168,004,724
G
Pnpla3
patatin-like phospholipase domain containing 3
decreases expression
ISO
Rutin results in decreased expression of PNPLA3 mRNA
CTD
PMID:17032037
NCBI chr 7:125,034,760...125,056,165
Ensembl chr 7:125,034,764...125,055,976
G
Pon1
paraoxonase 1
multiple interactions increases expression
EXP
Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON1 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON1 protein] Rutin results in increased expression of PON1 mRNA
CTD
PMID:25478064
NCBI chr 4:30,249,749...30,276,297
Ensembl chr 4:30,249,742...30,276,372
G
Pon3
paraoxonase 3
multiple interactions
EXP
Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 protein]
CTD
PMID:25478064
NCBI chr 4:30,311,981...30,338,679
Ensembl chr 4:30,311,982...30,338,679
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in decreased expression of PPARA protein]
CTD
PMID:22426011
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
G
Ppard
peroxisome proliferator-activated receptor delta
multiple interactions
EXP
Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARD mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARD protein]
CTD
PMID:25478064
NCBI chr20:7,818,289...7,883,482
Ensembl chr20:7,818,289...7,885,333
G
Ppid
peptidylprolyl isomerase D
multiple interactions
EXP
Rutin inhibits the reaction [Oxidopamine results in increased expression of PPID mRNA]
CTD
PMID:25129099
NCBI chr 2:178,354,830...178,366,843
Ensembl chr 2:178,354,890...178,366,685
G
Prkn
parkin RBR E3 ubiquitin protein ligase
multiple interactions
EXP
Rutin inhibits the reaction [Oxidopamine results in increased expression of PRKN mRNA]
CTD
PMID:25129099
NCBI chr 1:48,880,015...50,069,998
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions decreases expression
ISO EXP
[Rutin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of PTGS2 mRNA; Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 protein] Rutin results in decreased expression of PTGS2 mRNA Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein]; Rutin inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]; Rutin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] Rutin inhibits the reaction [Cyclophosphamide results in increased expression of PTGS2 protein]
CTD
PMID:11500931 PMID:15652231 PMID:19557821 PMID:21756928 PMID:22902988 PMID:25080890 PMID:25753322 PMID:28693884
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
G
Pycard
PYD and CARD domain containing
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in increased expression of PYCARD protein]
CTD
PMID:22426011
NCBI chr 1:199,438,029...199,439,062
Ensembl chr 1:199,437,832...199,439,210
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein]; Rutin inhibits the reaction [Glucose affects the localization of RELA protein]; Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of RELA protein] Rutin inhibits the reaction [Carbon Tetrachloride affects the localization of RELA protein]
CTD
PMID:19557821 PMID:21756928 PMID:29522708
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
G
Sirt1
sirtuin 1
increases expression
EXP
Rutin results in increased expression of SIRT1 mRNA; Rutin results in increased expression of SIRT1 protein
CTD
PMID:30365940
NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199
G
Slamf1
signaling lymphocytic activation molecule family member 1
increases expression multiple interactions
EXP
Rutin results in increased expression of SLAMF1 protein Lipopolysaccharides inhibits the reaction [Rutin results in increased expression of SLAMF1 protein]
CTD
PMID:28693884
NCBI chr13:90,184,545...90,219,170
Ensembl chr13:90,184,569...90,219,217
G
Slc22a1
solute carrier family 22 member 1
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in decreased expression of SLC22A1 mRNA]; Rutin inhibits the reaction [Fructose results in decreased expression of SLC22A1 protein]
CTD
PMID:19605544
NCBI chr 1:48,273,639...48,300,645
Ensembl chr 1:48,273,611...48,300,655
G
Slc22a12
solute carrier family 22 member 12
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in increased expression of SLC22A12 mRNA]; Rutin inhibits the reaction [Fructose results in increased expression of SLC22A12 protein]
CTD
PMID:19605544
NCBI chr 1:221,910,787...221,919,277
Ensembl chr 1:221,910,767...221,919,301
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in decreased expression of SLC22A2 mRNA]; Rutin inhibits the reaction [Fructose results in decreased expression of SLC22A2 protein]
CTD
PMID:19605544
NCBI chr 1:48,318,025...48,360,219
Ensembl chr 1:48,317,995...48,360,261
G
Slc22a6
solute carrier family 22 member 6
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in decreased expression of SLC22A6 mRNA]; Rutin inhibits the reaction [Fructose results in decreased expression of SLC22A6 protein]
CTD
PMID:19605544
NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259
G
Slc2a9
solute carrier family 2 member 9
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in increased expression of SLC2A9 mRNA SNP]; Rutin inhibits the reaction [Fructose results in increased expression of SLC2A9 protein SNP]
CTD
PMID:19605544
NCBI chr14:77,067,537...77,192,702
Ensembl chr14:77,067,503...77,192,702
G
Slco1b2
solute carrier organic anion transporter family member 1B2
multiple interactions
ISO
Rutin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein]
CTD
PMID:22394605
NCBI chr 4:175,814,118...175,881,775
Ensembl chr 4:175,814,118...175,881,768
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
affects localization multiple interactions
ISO
Rutin affects the localization of SLCO2B1 protein Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of Cholic Acid]; Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of estrone sulfate]; Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of Rosuvastatin Calcium]; Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of Taurocholic Acid]
CTD
PMID:24285294
NCBI chr 1:164,623,313...164,671,612
Ensembl chr 1:164,623,599...164,671,577
G
Smad2
SMAD family member 2
multiple interactions
EXP
Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of SMAD2 mRNA]
CTD
PMID:27239252
NCBI chr18:72,550,107...72,612,078
Ensembl chr18:72,550,219...72,612,078
G
Smad4
SMAD family member 4
multiple interactions
EXP
Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of SMAD4 mRNA]
CTD
PMID:27239252
NCBI chr18:69,626,682...69,657,373
Ensembl chr18:69,627,757...69,671,199
G
Socs3
suppressor of cytokine signaling 3
multiple interactions
EXP
Rutin inhibits the reaction [Fructose results in increased expression of SOCS3 protein]
CTD
PMID:22426011
NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
Rutin inhibits the reaction [Carbon Tetrachloride results in decreased activity of SOD1 protein]
CTD
PMID:22902988
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
G
Sord
sorbitol dehydrogenase
multiple interactions
ISO
[Rutin co-treated with Meloxicam] inhibits the reaction [Formaldehyde affects the activity of SORD protein]; Rutin inhibits the reaction [Formaldehyde affects the activity of SORD protein]
CTD
PMID:29315975
NCBI chr 3:114,176,127...114,207,368
Ensembl chr 3:114,176,309...114,207,366
G
Star
steroidogenic acute regulatory protein
increases expression
EXP
Rutin results in increased expression of STAR protein
CTD
PMID:29899696
NCBI chr16:71,036,204...71,040,847
Ensembl chr16:71,036,204...71,040,847
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
EXP
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of STAT3 mRNA]; Rutin inhibits the reaction [Fructose results in increased phosphorylation of STAT3 protein]
CTD
PMID:22426011 PMID:26062544
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Tgfa
transforming growth factor alpha
multiple interactions
ISO
Rutin inhibits the reaction [TGFA protein affects the localization of EGFR protein]
CTD
PMID:21967610
NCBI chr 4:117,961,877...118,045,923
Ensembl chr 4:117,962,319...118,046,344
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO EXP
Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein] Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of TGFB1 mRNA]; Rutin inhibits the reaction [Isoproterenol results in increased expression of TGFB1 mRNA]; Rutin inhibits the reaction [Isoproterenol results in increased expression of TGFB1 protein]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of TGFB1 mRNA]
CTD
PMID:22902988 PMID:24117263 PMID:27239252 PMID:28693884
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
G
Th
tyrosine hydroxylase
multiple interactions
EXP
Rutin inhibits the reaction [Oxidopamine results in decreased expression of TH mRNA]
CTD
PMID:25129099
NCBI chr 1:216,073,034...216,080,287
Ensembl chr 1:216,073,031...216,080,287
G
Tnf
tumor necrosis factor
multiple interactions decreases expression
ISO EXP
Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased phosphorylation of RELA protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein]; Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL8 protein]; Rutin inhibits the reaction [Glucose results in increased expression of TNF mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of TNF protein] Rutin results in decreased expression of TNF mRNA; Rutin results in decreased expression of TNF protein Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] Rutin inhibits the reaction [Carrageenan results in increased expression of TNF protein]; Rutin inhibits the reaction [Cisplatin results in increased expression of TNF protein]; Rutin inhibits the reaction [Cyclophosphamide results in increased expression of TNF protein]; Rutin inhibits the reaction [Fructose results in increased expression of TNF protein]
CTD
PMID:14654164 PMID:18958421 PMID:19557821 PMID:21605616 PMID:21756928 PMID:22426011 PMID:22902988 PMID:25753322 PMID:28693884 PMID:29743444
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tp53
tumor protein p53
multiple interactions
EXP ISO
Rutin inhibits the reaction [Cholesterol, Dietary results in increased expression of TP53 mRNA] Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of TRP53 protein]
CTD
PMID:27239252 PMID:29522708
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Uchl1
ubiquitin C-terminal hydrolase L1
multiple interactions
EXP
Rutin inhibits the reaction [Oxidopamine results in increased expression of UCHL1 mRNA]
CTD
PMID:25129099
NCBI chr14:43,133,224...43,143,942
Ensembl chr14:43,133,218...43,143,973
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
ISO
Rutin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of VCAM1 protein]
CTD
PMID:25080890
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
G
Vegfa
vascular endothelial growth factor A
multiple interactions decreases expression
ISO
Rutin results in decreased secretion of and results in decreased expression of VEGFA protein; Rutin results in increased susceptibility to [Vitamin E results in decreased expression of VEGFA mRNA]; Rutin results in increased susceptibility to [Vitamin E results in decreased secretion of and results in decreased expression of VEGFA protein]; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of VEGFA mRNA]; Vitamin E results in increased susceptibility to [Rutin results in decreased secretion of and results in decreased expression of VEGFA protein]
CTD
PMID:20015448
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Xdh
xanthine dehydrogenase
multiple interactions
EXP
Rutin inhibits the reaction [Cyclophosphamide results in increased activity of XDH protein]
CTD
PMID:25753322
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all